The QualityStocks Daily Monday, August 17th, 2020

Today's Top 3 Investment Newsletters

Profitable Trader Authority (FDIT) +62.50%

QualityStocks (ITHUF) +52.46%

MarketClub Analysis (REDU) +46.10%

The QualityStocks Daily Stock List

Anchiano Therapeutics Ltd. (ANCN)

Zacks, Whale Wisdom, Street Insider, Fosters Research, Stockhouse, InvestorsHub, iwatchmarkets, Stocklight, Stockwatch, Market Screener, YCharts, Investcom.com, Barchart, MacroTrends, BioPharmCatalyst, GlobeNewswire, TipRanks, Streetwise Reports, Simply Wall St, GuruFocus, Investing.com, Finviz, Investors Observer, Nasdaq, Business Insider, ChartMill, Seeking Alpha, Infront Analytics, TMXmoney, Webull, docoh, Stocknews, Stocktwits, and MarketWatch reported earlier on Anchiano Therapeutics Ltd. (ANCN), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Anchiano Therapeutics Ltd. is a preclinical biopharmaceutical company. Its dedication is to the discovery and development of new cancer therapies designed to target the products of mutated genes that are drivers of human malignancies. The Company previously went by the name BioCancell Ltd. It changed its name to Anchiano Therapeutics Ltd. in July of 2018. Established in 2004, Anchiano Therapeutics is headquartered in Cambridge, Massachusetts.

Anchiano is developing small-molecule pan-mutant-RAS inhibitors and inhibitors of PDE10 and the b-catenin pathway. It has a partnership with ADT Pharmaceuticals around two small molecule development programs targeting oncogenic pathways, centered on RAS and PDE10/ß-catenin, respectively.

RAS plays a key role in signal transduction pathways leading to tumor cell proliferation and survival. The Company’s program has identified novel indene-based small molecules that exhibit potent and selective inhibition of activated RAS signaling regardless of isoform or mutation, or pan-RAS inhibition.

Regarding the PDE10/ß-catenin Program, Anchiano Therapeutics’ program has identified small molecules that selectively and potently inhibit PDE10 and suppress Wnt/β-catenin signaling in preclinical models. PDE10 inhibition has been shown to down regulate β-catenin expression and inhibits polyp and tumor growth. It has potential for application in the treatment of cancer and also spontaneous and familial polyposis syndromes.

This past May, Anchiano Therapeutics announced that Mr. Stan Polovets was elected Chairman of its Board of Directors. Mr. Polovets joined the board of Anchiano Therapeutics in April of this year. He previously served as Chief Executive Officer of AAR, a private equity firm with an international energy portfolio. He presently serves as a member of the Board of Overseers of New York University (NYU) Tandon School of Engineering, NYU President’s Global Council, and the Council on Foreign Relations. In May, Anchiano Therapeutics reported financial results for its Q1 ended March 31, 2020. Cash and Cash Equivalents as of March 31, 2020 were roughly $14.0 million, versus $17.6 million as of December 31, 2019.

Financing Income, net for the quarter ended March 31, 2020 was $10,000. Finance Expense, net in the quarter ended March 31, 2019 was $4.5 million. Net Loss for the quarter ended March 31, 2020 was roughly $3.5 million versus roughly $9.9 million for the same period in 2019.

Anchiano Therapeutics Ltd. (ANCN), closed Monday’s trading session at $1.10, off by 5.1724%, on 89,052 volume with 312 trades. The average volume for the last 3 months is 116,046 and the stock's 52-week low/high is $0.513626992/$3.00.

chart

Antares Pharma, Inc. (ATRS)

Zacks, BioPharmCatalyst, Investor Village, Stock Register, Stocktwits, Stocknews, Seeking Alpha, Nasdaq, ETF.com, CSI Market, Simply Wall St, Morningstar, Stockhouse, Investing.com, Invest Chronicle, Street Insider, Proactive Investors, YCharts, Research and Markets, TMXmoney, GuruFocus, TradingView, Directors Talk Interviews, Stock Consultant, Market Screener, InvestorsHub, Barchart, DBT News, Macrotrends, ETF Channel, and GlobeNewswire reported beforehand on Antares Pharma, Inc. (ATRS), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Antares Pharma, Inc. focuses primarily on the development and commercialization of self-administered injectable pharmaceutical products utilizing advanced drug delivery auto injector technology. A pharmaceutical technology company, it has a portfolio of proprietary and partnered commercial products with several product candidates in various stages of development. The Company’s aim is to improve dosing, reduce side effects, and improve patient compliance and outcomes. Established in 1978, Antares Pharma is headquartered in Ewing, New Jersey.

Antares’ FDA (Food and Drug Administration) approved products include XYOSTED® (testosterone enanthate) injection; OTREXUP® (methotrexate) injection for subcutaneous use; and Sumatriptan Injection USP, which is distributed by Teva. It focuses on self-injection, pharmaceutical products, and also technologies with a focus in rheumatology, urology, endocrinology, and neurology. Antares Pharma has significant strategic alliances with industry leading pharmaceutical companies. These include Teva Pharmaceutical Industries, Ltd. (Teva), AMAG Pharmaceuticals, Inc. (AMAG), Pfizer, Inc. (Pfizer), and Idorsia Pharmaceuticals Ltd. (Idorsia).

XYOSTED® is the first and only weekly auto-injector testosterone therapy. Otrexup™ has been prescribed more than 140,000 times to patients with active rheumatoid arthritis, children with active polyarticular juvenile idiopathic arthritis, and adults with severe, resistant, disabling psoriasis.

Sumatriptan injection is used to treat acute migraine with or without aura, and acute cluster headaches in adults. Sumatriptan Injection USP represents Antares’ first ANDA approval of a complex generic and second product approved using the VIBEX® auto injector platform.

Recently, Antares Pharma announced the first commercialization of its multi-dose pen platform launched in Europe. Antares development partner Teva, launched Teriparatide Injection (teriparatide), the generic version of Eli Lilly’s brand product Forsteo® featuring the Antares multi-dose pen platform in Austria, Croatia, Hungary, The Netherlands, Portugal, Sweden, Switzerland, and The United Kingdom (UK). It is expected to launch in other European countries later this year.

Antares Pharma this month reported operating and financial results for Q2 ended June 30, 2020 with record second quarter Revenue of $32.4 million and Net Income of $2.2 million, or Earnings Per Share of $0.01. In addition, Antares reported record six-month year-to-date Revenue of $65.5 million. This represents a 27 percent increase in comparison to the first six months of 2019.

Mr. Robert F. Apple, President and Chief Executive Officer of Antares Pharma, said, “The Company’s second quarter revenue of $32.4 million, which represents 14% year-over-year growth, was primarily driven by our proprietary product XYOSTED… Revenue from proprietary products, XYOSTED and OTREXUP, our highest margin products, grew 65% in the quarter versus the same period last year and now represent 60% of our total product revenue.”

Antares Pharma, Inc. (ATRS), closed Monday’s trading session at $2.94, off by 0.338983%, on 664,378 volume with 2,789 trades. The average volume for the last 3 months is 1,070,776 and the stock's 52-week low/high is $1.60000002/$5.13000011.

chart

International Land Alliance, Inc. (ILAL)

OTC Markets, Dividend Investor, last10k, TipRanks, Investors Hangout, Predict Wall Street, Stockwatch, FX Empire, GlobeNewswire, Stockopedia, InvestorsHub, Stocktwits, TradingView, Stock News, Stock Charts, Simply Wall St, Nasdaq, Morningstar, Finviz, and wallstreet-online reported previously on International Land Alliance, Inc. (ILAL), and today we report on the Company, here at the QualityStocks Daily Newsletter.

International Land Alliance, Inc. is a global land investment and development company. Its focus is on acquiring attractive raw land mainly in Northern Baja California, often within driving distance from Southern California. The Company’s main objective is to sell desirable properties, at competitive prices, with favorable financing options for individual purchases and/or bulk purchases suitable for all types of investors and buyers. International Land Alliance is based in San Diego, California. The Company lists on the OTCQB.

International Land Alliance provides the option of financing with a guaranteed acceptance on any purchase for every customer. Through removing the middleman, loans are approved directly by the Company. This provides easy and affordable financing terms. Furthermore, there are no prepayment penalties, credit or background checks, and there are very competitively low interest rates.

The Company’s inventory includes residential, commercial, recreational, waterfront, ranch, hotel, and marina properties. International Land Alliance, by way of its wholly-owned subsidiary, International Land Alliance, S.A. de C.V, a Mexican corporation, is the owner of 123 residential lots and commercial lots comprising 20-acres, named Valle Divino, in Ensenada, Baja California.

International Land Alliance is also the owner of 1,344 residential lots and commercial lots comprising 497-acres, named Oasis Park Resort, in San Felipe, Baja California. The Oasis Park Resort and Valle Divino Resort projects will undergo development as a second home resort or retirement destination in a planned community setting. The Company’s Villas Del Enologo at Rancho Tecate is a 2.6 acre parcel within the prestigious Rancho Tecate. It is a planned 24 -2B/2B Vineyard Villas with private wine cellar.

International Land Alliance closed in 2019 on the purchase of 80 acres, the Emerald Grove Estates, and an 8,000 square foot event facility, the Chateau at Emerald Grove, in the wine country in Southern California for $1.1 million. The Company entered into a 3-year lease with future plans of development.

International Land Alliance has also entered into a joint venture (JV) to co-develop 150 homes at the Bajamar Ocean Front Golf Resort. The Bajamar Ocean Front Golf Resort is a master planned golf community located 45 minutes south of the San Diego-Tijuana Border. This new project is branded "The Plaza at Bajamar".

This past May, International Land Alliance announced that it entered into a JV to co-develop 500 homes adjacent to its Valle Divino project. The new addition will be branded "the Plaza at Valle Divino."

In July, the Company announced that it broke ground and began construction on Valle Divino, the eco-friendly development in Ensenada, Baja California, approximately 50 miles south of San Diego. This community will feature 650 homesites. It is part of a master planned residential community overlooking the internationally-renowned Bajamar Ocean Front Hotel and Golf Resort, as well as the Pacific Ocean.

International Land Alliance, Inc. (ILAL), closed Monday’s trading session at $0.41, even for the day, on 1,253 volume with 4 trades. The average volume for the last 3 months is 11,061 and the stock's 52-week low/high is $0.059999998/$1.40999996.

chart

Nocopi Technologies, Inc. (NNUP)

MarketWatch, MarketBeat, Stock of the Week, OTC Markets, Insider Monkey, last10k, CSI Market, Infront Analytics, OTC Dynamics, Micro Cap Daily, Insider Financial, TipRanks, InvestorsHub, YCharts, Investing.com, Finbox, Wallet Investor, Simply Wall St, GlobeNewswire, Market Screener, The Stock Market Watch, Stockhouse, Small Cap Network, Stockopedia, Seeking Alpha, Dividend Investor, Proactive Investors, and Morningstar reported earlier on Nocopi Technologies, Inc. (NNUP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Nocopi Technologies, Inc. develops specialty reactive inks used in entertainment, toy, and educational products and also in document and product authentication technologies to fight fraudulent document reproduction, product counterfeiting, and/or unauthorized product diversion. The Company operates in North America, Europe, South America, Asia, and Australia. Nocopi Technologies lists on the OTC Markets. The Company has its head office in King of Prussia, Pennsylvania.

Nocopi Technologies garners revenue from technology licensing agreements. It also garners revenue from the sale of its proprietary inks and other products to licensees and/or their licensed printers. The Company’s products and systems include trade secrets and patented technologies. Nocopi currently has patent protection on substantially all of its security inks.

Nocopi Technologies develops specialty reactive inks that are invisible when printed but transform into vibrant colors when scratched or written on with proprietary developing agents. The Company’s innovative technology has been proven commercially valuable for an increasing base of consumer products and in security applications for worldwide brands across automotive, cosmetics, pharmaceuticals, fragrances, and other sectors.

Nocopi inks and clear developing agents enable an array of mess-free activity books, coloring books, and other printed items for entertainment and educational applications, targeted mainly at children. The Company licenses its ink technology to produce a range of activity books for sale globally. Nocopi-powered products are available in more than 80,000 retail outlets throughout North America and online. “Invisible” Nocopi Technologies inks are printed on packaging, labels, forms, and more. They are revealed by the customer using an assortment of security market methods. Nocopi is “embedded” with a number of long-term Fortune 500 customers. The Company states that he sales cycle can be slow. However, the business is recurring and offers considerable growth potential. Last week, Nocopi Technologies announced results for its Q2 ended June 30, 2020. Revenues increased 22 percent to $627,300, propelled by a 61 percent increase in Product Sales. Net Income decreased to $70,800 from $148,900 in Q2 2019. Nocopi Technologies Chairman and Chief Executive Officer, Mr. Michael Feinstein, said, “Nocopi achieved double digit revenue growth for the fourth consecutive quarter reflecting strong demand for specialty inks and the COVID-19-related shifting of some ink shipments from Q1 to Q2 due to temporary printing plant closures… While the COVID-19 pandemic impacted both our top- and bottom-line performance in Q2, we remained solidly profitable in the period…”

Nocopi Technologies, Inc. (NNUP), closed Monday’s trading session at $0.209, up 4.50%, on 188,150 volume with 41 trades. The average volume for the last 3 months is 97,917 and the stock's 52-week low/high is $0.025699999/$0.250999987.

chart

Target Hospitality Corp. (TH)

Analyst Rating, Market Chameleon, Whale Wisdom, Stocktwits, TipRanks, Simply Wall St, TradingView, Investing.com, last10k, Business Wire, Dividend.com, Morningstar, Barchart, S&P Global Market Intelligence, Directors Talk Interviews, Seeking Alpha, Nasdaq, GuruFocus, YCharts, ETF.com, Stocks.TradingCharts, and Investors Observer reported previously on Target Hospitality Corp. (TH), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Target Hospitality Corp. is the largest provider of vertically-integrated specialty hospitality accommodations with premium catering and value-added hospitality services in the U.S. It builds, owns, and operates customized housing communities for a range of end users. The Company offers a full set of cost-effective hospitality solutions. These include culinary, catering, concierge, laundry, security services, and recreational facilities. Target Hospitality is headquartered in The Woodlands, Texas.

In essence, the Company is a global provider of turnkey accommodations and hospitality solutions. It coordinates every component of building and operating a workforce lodging community. Target Hospitality custom builds workforce housing accommodations to fulfill any need or specification. This is from basketball courts to BBQ pits, catering to housekeeping services, 24-hour travel professionals to on-site transportation management.

The Company primarily serves the energy and government sectors. It handles everything and outsources nothing. The design of its growing network of 25 communities with over 13,000 rooms is to maximize workforce productivity and satisfaction. Target Hospitality has been awarded the GSA Professional Services Schedule (PSS) contract enabling it to provide logistics solutions to government agencies. The Company provides a broad range of housing, deployment, operations, and management services via its GSA Professional Services Schedule agreement.

Target Hospitality has its Lodge Network. Its existing lodges provide value to companies and accommodations. Target offers a fully operating Housing Community that is already up and running. It offers turnkey accommodations and hospitality solutions. The Company’s oil field hospitality and lodge management services include Catering; Accounting; Security, and Communications. Additionally, Oil field hospitality and lodge management services include Maintenance/Housekeeping; Laundry; HSE, and Quality Control/Assurance.

Pertaining to Temporary Workforce Housing, Target provides temporary oil field housing, temporary apartments in an Olympic village, or housing for disaster relief workers. It customizes to a client’s needs and preferences and provides short-term, long-term, affordable, and comfortable turnkey accommodations and hospitality solutions.

This past May, Target Hospitality announced that Ms. Joy Berry was appointed to its Board of Directors as a Class III Director effective May 20, 2020. Ms. Berry joins the Target Board with more than 35 years of real estate and hospitality experience. She served as the Chief Operating Officer at Luxe Collection, a curated community of 4- and 5-star luxury properties in prime destinations globally.

Last week, Target Hospitality reported results for the three months ended June 30, 2020. The Company had Revenues of $53.6 million for the three months ended June 30, 2020 versus $81.4 million for the same period in 2019. It had Net Income (Loss) of $(14.2) million for the three months ended June 30, 2020, versus a Net Income of $10.6 million for Q2 of 2019.

Target Hospitality Corp. (TH), closed Monday’s trading session at $1.55, off by 6.0606%, on 112,122 volume with 679 trades. The average volume for the last 3 months is 251,749 and the stock's 52-week low/high is $1.19000005/$7.32000017.

chart

The ONE Group Hospitality, Inc. (STKS)

MarketWatch, Stock Market Daily, Stocktwits, MarketBeat, Zacks, Seeking Alpha, TMXmoney, Morningstar, Nasdaq, Business Wire, Investors Observer, YCharts, MacroTrends, Finviz, last10k, Stockhouse, Stocknews, Business Insider, Equity Clock, GuruFocus, Invest Chronicle, Wallet Investor, InvestorsHub, Finbox, TradingView, Investing.com, Market Screener, and Simply Wall St reported earlier on The ONE Group Hospitality, Inc. (STKS), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

The ONE Group Hospitality, Inc. is an international leader in the hospitality industry and the creator of the global restaurant brand STK. The Company develops and operates upscale, high-energy restaurants and lounges. It also provides a signature turn-key food and beverage service - ONE Hospitality - for hotels, casinos, and other high-end locations worldwide. The Company operates restaurants mainly under the STK and Kona Grill brands. Established in 2004, The ONE Group Hospitality has its corporate headquarters in Denver, Colorado.

The Company’s focus is to be the worldwide leader in Vibe Dining. Its STK is a modern twist on the American steakhouse concept with 20 restaurants in major metropolitan cities in the United States, Europe, and the Middle East.

Its Kona Grill is a polished, casual, bar-centric grill brand with 24 restaurants in the United States. Kona Grill features American favorites, award-winning sushi, and specialty cocktails in an upscale casual atmosphere.

The ONE Group Hospitality’s hospitality food and beverage solutions include developing, managing, and operating restaurants, bars, rooftops, pools, banqueting, catering, private dining rooms, room service, and mini bars.

Last week, The ONE Group Hospitality reported its financial results for Q2 ended June 30, 2020. Total GAAP Revenues decreased 29.4 percent to $16.7 million from $23.6 million. Consolidated Comparable Sales decreased 66.7 percent, but improved sequentially through the quarter.

Mr. Emanuel "Manny" Hilario, President and Chief Executive Officer of The ONE Group Hospitality, said, “…We are encouraged by the continued sequential improvement in our comparable sales results, which includes our curbside and delivery business, as trends have strengthened month over month through July. Kona Grill has rebounded extremely well from the effects of COVID-19 shutdowns, driven by strong operations and marketing and aided by its suburban footprint…”

The ONE Group Hospitality implemented measures to lessen its costs during the COVID-19 pandemic beginning in March 2020. This included the furlough of employees, deferral of capital projects, and negotiations with suppliers and landlords concerning deferral or abatement of payments. As of June 30, 2020, the Company had $23.5 million in Cash and cash Equivalents.

The ONE Group Hospitality, Inc. (STKS), closed Monday’s trading session at $2.00, off by 3.8462%, on 188,460 volume with 602 trades. The average volume for the last 3 months is 88,661 and the stock's 52-week low/high is $0.730000019/$4.67999982.

chart

Williams Industrial Services Group, Inc. (WLMS)

Zacks, Whale Wisdom, OilandGas360, Market Screener, MarketBeat, Proactive Investors, TradingView, CRWE World, Morningstar, Street Insider, Smarter Analyst, Corporate Information, TipRanks, OTC Markets, Dividend.com, PR Newswire, MarketWatch, Finbox, Barchart, Market Wire News, last10k, Global Banking and Finance, InvestorsHub, OTC.Watch, Simply Wall St, GuruFocus, Stockopedia, Nasdaq, TMXmoney, and Seeking Alpha reported earlier on Williams Industrial Services Group, Inc. (WLMS), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Williams Industrial Services Group, Inc. is a construction and maintenance services company listed on the OTC Markets Group’s OTCQX. It provides a wide range of construction, maintenance and modification, and support services to customers in energy, power, and industrial end markets. The Company previously went by the name Global Power Equipment Group, Inc. It changed its corporate name to Williams Industrial Services Group, Inc. in June of 2018. Founded in 1958, Williams Industrial Services Group is headquartered in Tucker, Georgia.

Williams’ provides Plant Services, Specialty Services, as well as Industrial Services. Regarding Plant Services, the Company is a foremost provider of complete plant maintenance and modifications services, capital construction, and a broad array of specialty and support services to its clients in the power generation, oil and gas, pulp and paper, and other heavy industrial markets. Services include support for continuing plant operations, regularly scheduled and emergency outages, refueling, shutdowns, turnarounds, and other major maintenance projects needed by its clients.

Williams Industrial Services Group is a multi-industry leader in Specialty Services. The Company has set the standard for protective coatings application, insulation, roofing systems, asbestos and lead abatement, and other maintenance specialties in a variety of industrial markets.

Pertaining to Industrial Services, Williams’ provides almost all of the services provided by its Plant and Specialty Services companies - but in open shop labor environments. Work usually performed includes Facility Maintenance, Major Modifications, Outages, Shutdowns and Turnarounds, and New Construction. Main industries served include Water & Wastewater Treatment, Oil & Gas/Petrochemical, Pulp & Paper, and Power Generation.

For Q2 2020, Williams Industrial Services Group posted Revenue of $72.5 million versus $71.5 million in the prior-year period. Revenue rose roughly 10 percent sequentially in comparison to $66.1 million in Q1 of 2020. Williams’ reported Net Income of $2.5 million in Q2 of 2020 in comparison to $2.0 million in Q2 of 2019.

Williams Industrial Services Group, Inc. (WLMS), closed Monday’s trading session at $1.79, off by 0.555556%, on 49,439 volume with 30 trades. The average volume for the last 3 months is 35,242 and the stock's 52-week low/high is $0.870000004/$2.03999996.

chart

Stein Mart, Inc. (SMRT)

Zacks, Macrotrends, Stocktwits, StockNews, Market Screener, Street Insider, Market Chameleon, Proactive Investors, Investor Place, Morningstar, Business Insider, Dividend Investor, Simply Wall St, Barchart, Investing.com, Equities.com, CSI Market, YCharts, MarketBeat, InvestorsHub, Investor Point, GlobeNewswire, and MarketWatch reported previously on Stein Mart, Inc. (SMRT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Stein Mart, Inc. is a national specialty omni off-price retailer listed on the Nasdaq GS. The Company offers designer and name-brand fashion apparel for him and for her, home décor, accessories and shoes at everyday discount prices. Its shopping experience is more upscale, with an emphasis on ease-of-shopping, service and presentation of merchandise by category, brand, style and size. In addition, the Company sells its products via an e-commerce retail selling site. Established in 1908, Stein Mart is based in Jacksonville, Florida.

The Company began in the early 1900’s as a single store in Greenville, Mississippi. Today, Stein Mart operate almost 300 stores in 31 States, plus steinmart.com. Its stores are located in convenient regional, community and neighborhood shopping centers serving a more affluent customer. The Company’s customer is both style conscious and value seeking with above-average household income.

Stein Mart’s stores also provide merchandise locator services and a preferred customer program. In addition, they provide co-branded and private label credit card programs, as well as electronic gift cards.

As announced on January 31, 2020, Stein Mart has entered into a definitive merger agreement under which an affiliate of Kingswood Capital Management, L.P. will acquire all of the outstanding common stock of Stein Mart not already beneficially owned by affiliates of Mr. Jay Stein, Stein Mart’s former Chief Executive Officer and current Chairman of the Board of Directors, and related investors for $0.90 per share in cash. As part of the Merger, an entity managed by Mr. Stein will contribute its equity and, following the closing of the Merger, will indirectly own one-third of Stein Mart after closing. The expectation is that this Merger will be completed in the first half of this calendar year. It is subject to approval by Stein Mart’s shareholders and the satisfaction of other customary closing conditions.

For Q4 2019, Net Sales were $336.6 million versus $340.8 million for Q4 of 2018. Net Sales were affected by fewer stores operating during the quarter. Comparable sales for Q4 of 2019 increased 0.1 percent. Omni sales, defined as all online sales regardless of fulfillment channel, increased 7 percent over last year’s Q4.

For the year, Net Sales decreased 3.0 percent to $1.22 billion. Comparable Sales decreased 1.4 percent to last year. Net Sales were affected by fewer stores operating during the year and comparable sales results. Omni sales increased 11 percent over 2018.

Stein Mart, Inc. (SMRT), closed Monday’s trading session at $0.1521, up 39.0311%, on 111,238,459 volume with 70,510 trades. The average volume for the last 3 months is 4,205,133 and the stock's 52-week low/high is $0.100000001/$0.949999988.

chart

Whiting USA Trust II (WHZT)

Zacks, Street Insider, All Stocks Today, Wallstreet Online, Stockhouse, Global Banking and Finance, Simply Wall St, Marketbeat, MarketWatch, Barchart, and Dividend Investor reported previously on Whiting USA Trust II (WHZT), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Whiting USA Trust II holds a term net profits interest in the oil and gas producing properties located in the Permian Basin, Rocky Mountains, Gulf Coast, and Mid-Continent regions. Whiting USA Trust II is a subsidiary of Whiting Petroleum Corporation. The Company lists on the OTC Markets. Established in 2011, Whiting USA Trust II has its corporate office in Houston, Texas.

As of December 31, 2018, the Company’s oil and gas properties included interests in roughly 367.8 net producing oil and natural gas wells. These are situated in 46 predominately mature fields with established production profiles in 10 States.

Recently, Whiting USA Trust II announced that the Trust would make a distribution to unitholders in the second quarter of 2019. This relates to net profits generated during the first quarterly payment period of 2019. Unitholders of record on May 20, 2019 received a distribution of $0.140750 per unit that was payable on or before May 30, 2019.

The Trust’s net profits interest (NPI), the only asset of the Trust other than cash reserves held for future Trust expenses, represents the right to receive 90 percent of the net proceeds from Whiting Petroleum Corporation’s interests in certain existing oil and natural gas properties located mainly in the aforementioned Rocky Mountains, Permian Basin, Gulf Coast and Mid-Continent regions of the U.S.

As of March 31, 2019, on a cumulative accrual basis, 9.24 MMBOE (87 percent) of the Trust’s total 10.61 MMBOE have been produced and sold or divested. Based on the Trust’s reserve report for the underlying properties as of December 31, 2018, the projection is that the Trust’s 10.61 MMBOE will be produced prior to December 31, 2021, shortly after which the Trust would terminate. The 2018 year-end reserve report reflects expected annualized production decline rates of roughly 11.1 percent for oil and 23 percent for gas between 2019 and 2021.

The Company’s parent, Whiting Petroleum Corporation, is an independent oil and gas company. It develops, produces, acquires and explores for crude oil, natural gas and natural gas liquids mainly in the Rocky Mountains region of the U.S. The Company’s largest projects are in the Bakken and Three Forks plays in North Dakota and Montana and the Niobrara play in northeast Colorado.

Whiting USA Trust II (WHZT), closed Monday’s trading session at $0.1156, up 44.50%, on 43,295 volume with 28 trades. The average volume for the last 3 months is 50,703 and the stock's 52-week low/high is $0.039999999/$1.12999999.

chart

Elio Motors, Inc. (ELIO)

Green Car Reports, The Verge, Stock Twits, Start Engine, Zacks, Nasdaq, Marketbeat, Green Car Congress, Tmxmoney, Stockhouse, InvestorsHub, Seeking Alpha, Insider Financial, Barchart, Stockwatch, Business Wire, OTC Markets, 4-Traders, Wallet Investor, PR Newswire, and GuruFocus reported earlier on Elio Motors, Inc. (ELIO), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Elio Motors, Inc. is the developer of the ultra-high-mileage, low-cost, three-wheel Elio vehicle. Car enthusiast, Mr. Paul Elio, founded the Company. A development stage enterprise, Elio concentrates on developing the Elio three-wheeled vehicle for mass production in America. Elio Motors has its corporate headquarters in Phoenix, Arizona. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Elio Motors’ first manufacturing site will be in Shreveport, Louisiana. The Company is taking advantage of existing automotive technologies and partnerships with the world’s foremost automotive engineering firms and component suppliers, The three-wheel Elio is engineered to achieve a highway mileage rating of up to 84 mpg. This is while providing the comfort of amenities including power windows, power door locks, air conditioning and cruise control, accompanied by the safety of numerous air-bags and an aerodynamic, enclosed vehicle body.

In September of 2018, Elio Motors announced it entered into a Memorandum of Understanding (MOU) with a Fortune 500 original equipment manufacturer (OEM), to provide the engine foundation as part of a new powertrain for the Elio vehicle. In September, Elio projected that the new powertrain will result in $120 million in research and development (R&D) cost savings. Elio Motors is working with the engineering team at Roush to develop a new Elio prototype utilizing the OEM powertrain.

Roush will integrate the new powertrain into Elio Motors’ prototype in order to commence preliminary testing procedures. The testing procedures will prepare the Elio for production that will take place at the Elio Motors manufacturing facility in Shreveport, Louisiana.

The new powertrain will push the Elio's performance specifications considerably beyond previous consumer expectations. The engine should offer close to a 100 percent increase in horsepower rating versus initial Elio prototype vehicles. The expectation is that the new powertrain, when combined with the Elio's low curb weight, will deliver excellent driver response and a highly improved acceleration time.

Elio Motors, Inc. (ELIO), closed Monday’s trading session at $0.49, up 40.8248%, on 1,214 volume with 7 trades. The average volume for the last 3 months is 1,495 and the stock's 52-week low/high is $0.150000005/$1.29999995.

chart

iAnthus Capital Holdings, Inc. (ITHUF)

InvestorsHub, Stockhouse, MarketWatch, New Cannabis Ventures, GuruFocus, Daily Marijuana Observer, Morningstar, Barchart, OTC Markets, and Proactive Investors reported earlier on iAnthus Capital Holdings, Inc. (ITHUF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

iAnthus Capital Holdings, Inc. is a provider of capital investment and management services to licensed cannabis cultivators, processors, and dispensaries across the U.S. The Company, by way of its 100 percent owned subsidiary, iAnthus Capital Management, LLC, delivers a complete solution for financing and managing these enterprises. iAnthus supports a diverse portfolio of cannabis industry investments. OTCQX-listed, iAnthus Capital Holdings is headquartered in New York, New York.

iAnthus provides a unique combination of capital and practical operating and management expertise. The Company creates agreements that establish valuable partnerships. It has developed strategic partnerships with best-in-class industry-sector leaders in dispensary operations, commercial-scale cannabis cultivation, regulatory law, and the science of cannabis product formulation and testing. Moreover, iAnthus continues to market its award-winning line of MPX-branded products.

At present, iAnthus has operations in 11 states, and operates 20 dispensaries. The Company is rapidly progressing its long-term plan to install more than half-a-million square feet of cultivation at its Lake Wales, Florida, campus. iAnthus’ New York State operation is one of only ten licensed medical cannabis Registered Organizations in the State. In addition, the Company’s Brooklyn location opened in late 2018. It is one of only three stores serving a city of 2.6 million.

iAnthus Capital Holdings has opened two dispensaries in Florida. This includes its flagship store in West Palm Beach. iAnthus has plans to quickly expand through 2019. It will be adding roughly one store a month. At the same time, it will be expanding its cultivation and processing operations.

In the State of Massachusetts, iAnthus is building a 41,000-square-foot facility. It will accommodate a fully integrated license, which includes cultivation, production and a dispensary on 12 acres in the Fall River area. This is in addition to the Company’s 30,000-square-foot facility in Holliston. Furthermore, in Vermont, iAnthus has made major upgrades to its 6,000-square-foot cultivation and processing facility in Brandon. The Company has also started construction on a 49,700-square-foot medical cannabis cultivation and processing facility in Warwick, New York.

Recently, iAnthus Capital Holdings announced that it opened its second New York dispensary in the Dutchess County town of Wappingers Falls. This dispensary will operate as "Citiva Hudson Valley" under the iAnthus' "Citiva" New York dispensary brand. This retail location will initially offer greater than 30 locally-sourced, lab-tested products, including vape cartridges, tinctures, capsules, and powders, dispensed by highly-knowledgeable patient care representatives.

iAnthus Capital Holdings, Inc. (ITHUF), closed Monday’s trading session at $0.093, up 52.459%, on 3,362,858 volume with 925 trades. The average volume for the last 3 months is 677,746 and the stock's 52-week low/high is $0.046/$2.74.

chart

SusGlobal Energy Corp. (SNRG)

Simply Wall St, Penny Stock Hub, Trading View, Wallstreet Online, Market Screener, Dividend Investor, Barchart, Investors Hangout, Stocks News Feed, GuruFocus, Street Insider, Interactive Brokers, Law Insider, last10k, YCharts, Morningstar, and MarketWatch reported on SusGlobal Energy Corp. (SNRG), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

SusGlobal Energy Corp. is the developer of SusGro™, which is a pioneering pathogen free organic fertilizer. The Company is a renewables business centered on acquiring, developing, and monetizing a portfolio of proprietary technologies in the waste to energy and regenerative products application worldwide. SusGlobal Energy has its head office in Toronto, Ontario. The Company lists on the OTC Markets Group’s OTCQB.

SusGlobal Energy has the capability to provide a complete range of services for handling organic residuals. The Company has spent years attaining proprietary processes and combining different treatments. It also has many years of innovative experience and technical knowledge and thus can provide its clients with comprehensive solutions. SusGlobal Energy has projects in Belleville, Ontario; Hamilton, Ontario; and Florida.

SusGlobal Energy can, from beginning to end, offer in-depth knowledge, abundant experience and trailblazing technology for all a client’s needs in handling organic waste. Some of the Company’s work managing organic waste streams includes Anaerobic Digestion, Dry Digestion, Biogas Production, Wastewater Treatment, In-Vessel Composting, Source Separated Organics Treatment, Biosolids Heat Treatment and Composting.

The Company’s SusGro™ pathogen free organic fertilizer offers an economical, sustainable and highly effective alternative to traditional fertilization. SusGro™ is an organically-based, concentrated organic pathogen free liquid fertilizer product. It has a full complement of nutrients suitable for a broad spectrum of fertilization requirements.

In addition, SusGlobal Energy’s Earth’s Journey™ Compost enhances plant growth. The Company employs patented technology to transform organic waste into the most nutrient-rich organic compost, diverting organic waste from landfills and lessening Greenhouse Gas (GHG) emissions.

Recently, SusGlobal Energy announced that its wholly-owned subsidiary, SusGlobal Energy Belleville Ltd. (SusGlobal Belleville), executed a non-binding Letter of Intent (LOI) for certain assets, including 39.44 acres of property located at 704 Phillipston Road, in Belleville, Ontario. Subject to the execution of an Asset Purchase Agreement (APA), the LOI sets out the terms, including the purchase price of USD$1,332,153 (CAD$1,767,250) in cash to be paid on closing, minus the sum of USD$54,274 (CAD$72,000) advanced by SusGlobal Energy to the seller on February 5, 2019.

If the APA is signed, SusGlobal Belleville will become the owner of the 39.44 land parcel and no more a lessee of the existing 13.88-acre section. SusGlobal Belleville will be expanding the site capacity to 70,000 tonnes per annum from the present 35,000 tonnes per annum composting facility to continue producing its Earth's Journey™ Compost, with an additional 50,000 tonnes per annum organic processing and transfer site approved under the existing Environmental Compliance Approval (ECA) and Site Plan.

Mr. Marc Hazout, Executive Chairman and President of SusGlobal Energy, stated, "We are very pleased to be able to enter into an LOI to purchase this large parcel of land with the ECA attached in order to expand our Belleville site to bring the Ontario, Quebec and New York State organic waste management systems to a sustainable level by diverting from landfills."

SusGlobal Energy Corp. (SNRG), closed Monday’s trading session at $0.0198, up 41.4286%, on 1,123,517 volume with 58 trades. The average volume for the last 3 months is 123,186 and the stock's 52-week low/high is $0.005499999/$0.200000002.

chart

Black Sea Copper & Gold Corp. (BLSSF)

Stockhouse, Market Screener, InvestorsHub, MarketWatch, GuruFocus, Wallet Investor, Barchart, Investors Hangout, and Dividend Investor reported earlier on Black Sea Copper & Gold Corp. (BLSSF), and today we report on the Company, here at the QualityStocks Daily Newsletter. 

Black Sea Copper & Gold Corp. is a mineral exploration company that is active in the Black Sea region of Eastern Europe. Its commitment is to build a strong portfolio of high quality copper and gold projects with the potential to become world-class mining assets. Black Sea Copper & Gold has established a complement of local technical, logistical, community, and corporate support. The Company is headquartered in Vancouver, British Columbia and trade on the OTC Markets.

Black Sea’s mission is to quickly grow and advance a successful portfolio of projects in the West Tethyan Metallogenic Belt of Eastern Europe through discovery, acquisitions, and partnerships. Its projects include  Kalabak, Copper-Gold; and Zlatusha, Copper-Gold.

Black Sea Copper & Gold has demonstrated its ability to identify new copper-gold porphyry and epithermal targets. The Company believes that it has one of the most extensive proprietary geological/exploration databases for Eastern Europe in the industry. Black Sea has more than four years of regional experience technically and operationally within Bulgaria, Serbia, Turkey, and Romania.

Kalabak (100 percent owned) is about 10 km north of Ada Tepe in the Bulgarian Rhodope Mountains. Mineral potential at Kalabak was identified during Black Sea’s extensive reconnaissance exploration program in Bulgaria. As a result, the Company applied for and was awarded the Kalabak license in October of 2014. The Kalabak license area (191 km2) lies within a developing porphyry copper-gold belt in the southeastern sector of the Bulgarian Rhodope Mountains. 

Zlatusha is approximately 40 kilometers northwest of Sofia in western Bulgaria within the Srednogorie endowed arc segment of the West Tethyan Metallogenic Belt. The Zlatusha license area (195 km2) lies within a developing porphyry copper-gold/epithermal belt situated northwest of Sofia.

Black Sea Copper & Gold’s project pipeline includes Golaka, Copper-Gold, which is roughly 1 km from the Assarel Mine in the Panagyurishte Cu-Au trend in central Bulgaria. In addition, the Company’s project pipeline includes Coka Njalta, Copper-Gold, positioned approximately 5 km south of the Majdanpek Mine in the world-class Timok belt of eastern Serbia.

Black Sea’s project pipeline also includes Susulajka, Copper-Gold. This project is 12 km north of the Bor Mine in the world-class Timok belt of eastern Serbia.

In September 2018, Black Sea Copper & Gold announced it received its exploration and prospecting license from the Ministry of Energy for its 100 percent owned Zlatusha project. The exploration program by Black Sea has improved the understanding of the known target areas and has yielded numerous additional target areas. The 7 target areas are based on alteration/sulphide/oxide zones in conjunction with anomalous copper and gold.

Black Sea Copper & Gold Corp. (BLSSF), closed Monday’s trading session at $0.34, up 71.7172%, on 12,384 volume with 10 trades. The average volume for the last 3 months is 4,563 and the stock's 52-week low/high is $0.012/$0.340000003.

chart

Medibio Limited (MDBIF)

Awesome Penny Stocks, Wallet Investor, The Street, TradingView, Morningstar, Penny Stock Hub, Stockwatch, OTC Markets, Investing Online, Otc.Watch, Investors Hangout, Stockhouse, 4-Traders, and Global Banking and Finance reported earlier on Medibio Limited (MDBIF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Medibio Limited is a digital health company with offices in Melbourne (Vic), and Minneapolis, Minnesota. It has developed an objective testing system to assist in the screening, diagnosis, and treatment effectiveness of depression, chronic stress, and other mental health disorders. The test uses patented (and patent pending) circadian heart rate variability and cloud based proprietary algorithms to deliver a quantifiable measure to assist in clinical diagnosis. Medibio lists on the OTC Markets’ OTCQB.

Medibio is on course to commercialize its platform technology called the Digital Mental Health Platform. The basis of this is on patented biomarkers from the autonomic nervous system. The Company’s technology will provide a Diagnosis Aid to help General Practioners (GPs) and mental health clinicians. Medibio’s technology provides the first objective measure of stress. It provides a series of user and corporate dashboards for assessment and wellness partner interventions.

Regarding biomarker based objective diagnosis, a panel of circadian, sleep, and automatic system biomarkers enables automated, repeatable, and objective characterization of the impact of mental illness on the physiologic state. Medibio’s Digital Mental Health Platform is a device agnostic platform. It can ingest data from many devices. It is highly scalable, low cost, as well as easy to integrate.

Medibio announced in October 2018 the release of ilumen™. This is its product and platform for corporate customers. ilumen™ is a corporate wellness product providing employers the ability to offer biometric analysis and objective, data-driven feedback along with a mental wellness assessment to their employees.

This past November, Medibio announced that it signed an exclusive agreement with AIAA to undertake a pilot program for the latest release of its corporate health program, ilumen™. AIAA is one of Australia’s leading life insurers. AIAA is part of the AIA Group, which is the largest independent publicly listed pan-Asian life insurance group. It has a presence in 18 markets around the Asia-Pacific region. AIAA will have access to ilumen™ over a six-month period for its Australia and New Zealand employees.

Medibio Limited (MDBIF), closed Monday’s trading session at $0.012, up 41.1765%, on 25,100 volume with 3 trades. The average volume for the last 3 months is 12,509 and the stock's 52-week low/high is $0.002/$0.028.

chart

The QualityStocks Company Corner

Cybin Corp.

The QualityStocks Daily Newsletter would like to spotlight Cybin Corp..

Cybin Corp. announced that it has entered into a feasibility agreement with IntelGenx Corp., a leading drug-delivery company focused on the development and manufacturing of pharmaceutical delivery films (http://ibn.fm/TZeVy). The agreement outlines plans for the two companies to develop a fast-acting, orally dissolving film for the delivery of pharmaceutical-grade psilocybin.

Cybin Corp. is a Canada-based life sciences company focused on the pharmaceutical development of psychedelic products, as well as the functional mushroom market.

The early-stage company boasts an experienced management team featuring industry veterans from pharmaceutical and consumer product backgrounds who have run multiple clinical trials and collectively helped facilitate billions of dollars in product revenues. The team is dedicated to the development of products and protocols within the psychedelic, pharmaceutical and nutraceutical industries.

In particular, Cybin aims to further build upon and expand its intellectual property (IP) portfolio, which is structured around unique psilocybin delivery mechanisms that target a number of different therapeutic indications. In addition, the company has dedicated itself toward furthering its research and IP within the fields of synthetic compounds, extraction methods, the isolation of chemical compounds, new drug formulations and protocol regimes.

Serenity Life Sciences & Natures Journey Inc.

The company’s business model is centered around its two core subsidiaries, Serenity Life Sciences and Natures Journey Inc., which comprise Cybin’s two-pronged approach toward delivering fungi-derived psychedelic and medicinal products.

Serenity Life Sciences is focused on furthering research and development of psilocybin-based medications. Psilocybin is found in certain species of mushrooms and is a non-habit forming, naturally occurring psychedelic compound. Research into psilocybin has shown positive results for the treatment of depression, anxiety, PTSD, addiction, eating disorders, ADHD and other indications.

Natures Journey Inc. operates the Journey brand, which specializes in developing proprietary medicinal mushroom products that target and promote mental wellness, immune boosting detoxification and overall general health and wellbeing.

Partnership with the Toronto Centre for Psychedelic Science (TCPS)

Staying true to its axiom of being a research-first medicinal mushroom life sciences company, Cybin recently announced its entry into a strategic partnership with the Toronto Centre for Psychedelic Science (TCPS), with the goal of furthering its ongoing psilocybin research efforts and expanding Cybin’s psilocybin IP portfolio (http://nnw.fm/9EUkI).

“While there is evidence to support psilocybin as a treatment for certain indications, the Toronto Centre for Psychedelic Science is taking a clinical approach to prove or disprove the safety and efficacy of psilocybin-based microdosing through an open science approach,” Paul Glavine, CEO of Cybin, stated in a news release.

“We are excited to join forces with Cybin and to offer our expertise. A number of firms had approached TCPS, but Cybin demonstrated a superior commitment to high-quality research and integrity in product development. Our high standards for scientific rigor and transparency will find a fitting home within the culture Cybin is cultivating in Canada and abroad,” Thomas Anderson, co-founder of the Toronto Centre for Psychedelic Science, added.

Journey’s Product Monetization & Market Potential for Nutraceutical Supplements

Although Cybin is at the forefront of companies seeking to conduct clinical trials aimed at gaining regulatory approval for psilocybin and other psychedelic products, the company has also placed a great deal of emphasis on generating meaningful revenue from its very outset.

Cybin’s Journey brand has is launching a range of supplements comprised of popular fungi-derived ingredients such as Reishi, Lion’s Mane and Cordyceps. Purported to aid focus and concentration while promoting neurogenesis, Journey’s range of nutraceutical products provides Cybin with a crucial foothold within the non-psychedelic legal supplement market, which is valued at over $25 billion globally and growing at a 9% year-over-year rate.

Pharmaceutical Psychedelics

In addition to the company’s range of non-psychedelic supplements, Cybin has plans to carry out a clinical trial with a new delivery system for its psilocybin-based medications later this year. Ultimately, the company aims to enter into technology transfer agreements with global pharmaceutical companies after phase 1 & phase 2 clinical trials are complete in order to accelerate regulatory approvals in major indications in global markets with entire lifecycle product management.

With products such as psilocybin truffles already legal in nations such as the Netherlands, Jamaica and Bulgaria, Cybin has positioned itself to capitalize on an eventual legalization of psychedelic mushroom-derived products in the future. Working within a regulatory environment with strong similarities to that which dealt with cannabis prior to the industry’s eventual legalization by the Canadian government in 2018, Cybin is laying the groundwork for the moment pharmaceutical psychedelics gain acceptance in North America and abroad.

Amalgamation Agreement and Financing

Cybin recently announced its entry into an amalgamation agreement dated June 26, 2020, with Clarmin Explorations Inc. (TSX.V: CX) and 2762898 Ontario Inc., a wholly owned subsidiary of Clarmin (http://nnw.fm/w04LH). Completion of the transactions contemplated in the amalgamation agreement will result in the reverse takeover of Clarmin by Cybin.

In connection with the proposed transaction, Cybin plans to complete a “best-efforts” brokered private placement of subscription receipts of Cybin, with a syndicate of agents co-led by Stifel Nicolaus Canada Inc. (Stifel GMP) and Eight Capital, to raise a minimum of C$14 million ($10 million) and a maximum of C$21 million ($15 million), with a 15% agents’ option.

To date, Cybin has raised approximately C$10,400,000 through an initial financing round and its series A financing round.


Recent News

chart

Mobius Interactive Ltd.

The QualityStocks Daily Newsletter would like to spotlight Mobius Interactive Ltd..

Mobius Interactive Ltd. is an online gaming operator launching in September 2020 with a variety of unique offerings catering to diverse demographic groups. In partnership with Ultra Play, a leading eSports and iGaming platform, Mobius Interactive is seeking to attract a network of high-net-worth gamers from around the world through the use of loyalty and gamification programs designed to enhance customer engagement by leveraging state-of-the-art customer relationship management systems and joint-ventures with over 600 VIP and Master gaming affiliates.

Array of Brands

Mobius Interactive is seeking to target a variety of customer segments and geographies through its diverse brand offerings, including:

  • Aragon Casino: Austria, Finland, the Balkans, Canada, Africa and New Zealand
    Catering to consumers aged 21 to 45, Aragon Casino brands itself along the lines of medieval fantasy, mimicking elements from the likes of The Walking Dead and Game of Thrones.
  • Club Double: Austria, India, Brazil, Finland, Canada, Africa and New Zealand
    Targeting the 30 to 65 age demographic, Club Double is designed to exude a classic yet magical old Hollywood and vintage Miami & Las Vegas air.
  • MobiusBet: Germany, Austria, Switzerland, Brazil, Latin America, New Zealand and India
    MobiusBet is designed to appeal to the 18- to 38-year-old eSports community, bringing together loyalty programs, targeted gamification and product merchandising in one seamless package.

Key Differentiating Indicators

Mobius Interactive has designed its platform with a number of key differentiation traits relative to its target market. These include:

  • The use of affiliates: Mobius Interactive has partnered with over 600 VIP and Master gaming affiliates, who will introduce high-value players to the company’s award-winning iGaming platform. Mobius added over 150 proven affiliates in Europe, Brazil, Finland and New Zealand over a period of just 20 days.
  • eSports Focus: Mobius.Bet, Mobius Interactive’s dedicated eSports hub, will cater to the quickly growing eSports segment, which is expected to rise to a value of $1.7 billion in 2021. With Mobius’ COO being one of the original founders of the eSports.com brand, the company aims to capitalize on this growing segment of the gaming industry.
  • Customer Relationship Management (CRM): Mobius has partnered with Solitics, a new and real-time CRM system, enabling the company to personalize customers’ gaming experiences in an interactive and highly intelligent manner.
  • Loyalty & Gamification: Mobius Interactive is set to introduce a unique loyalty and gamification program designed to increase customer engagement from signup. Loyalty and gamification programs have been proven to increase daily active wagering volumes by 30% while simultaneously increasing daily player activity by 60%. Furthermore, the introduction of these programs can help lower the company’s customer acquisition costs while adding a differentiating element to its platform.

Partnership with Puurl

Puurl provides a solution that embeds eGaming platforms into any existing online e-commerce store. First, shoppers can install the Puurl add-on to their browsers. Then, when visiting their preferred e-commerce stores, players will be prompted to bet, with the potential to win the products they’re browsing. The Puurl solution enables e-commerce operators and eGaming platforms to earn additional gambling revenues – even when their players are shopping. Through its partnership with Puurl, Mobius Interactive will look to add a unique revenue stream to complement its core business operations.

Management Team

Lynn Pearce, CEO, is an experienced, data-driven, commercially focused, strategic brand marketer with over 15 years of proven success in the global gaming industry, from land-based casinos in the UK to online gaming companies offering sports betting, poker and casino games. She was head-hunted to join a startup in Prague that launched 26 casinos, becoming profitable within the first three months of operation, before she relocated to Malta to join a leading B2B casino software development company as head of marketing, where she led global marketing, PR, product development, branding and go-to-market campaigns, retaining full control of a six-month budget of €1 million to increase brand awareness and customer engagement. She recently returned to the B2C side of gaming to launch three new brands in Germany, Brazil and India. She writes articles regularly for Infinity Gaming Magazine and has been a judge for the prestigious International Gaming Awards, a significant event for the gaming industry held each year prior to the largest gaming exhibition of the year, ICE London.

Robin Lawson, Vice President & COO, has been involved in iGaming for over 10 years, successfully founding two VIP casino departments across international locations in Latin America, as well as startup company Tabella in Europe. He most recently co-founded and acted as COO for eSports.com, which raised over $5.5 million as a startup ICO and was sold to German media giant ProSieben. Lawson is also a senior iGaming consultant for startup casino groups and an advisor to blockchain-based tech groups. His long-time experience and proven track record in startup organizations demonstrate his operational leadership skills.

Nicholas de Freitas, Vice President, Marketing, is one of the pioneers of digital stills photography for major retail companies in Africa and Australia. He left to start up UrbanActive, an outsourcing agency, working as marketing project manager and implementing major retail projects. He received his certification in digital marketing from the University of Stellenbosch. He has worked over the past few years as the marketing manager for various poker rooms and casinos, liaising and building relationships with software developers, successfully implementing a number of casino and poker products and holding regular weekly report sessions with the heads of all divisions of the company, spanning South Africa, Canada, Malta, Norway and Costa Rica.

Gary Eldridge, Chairman, is an experienced entrepreneur with a history of working in the venture capital and private equity industry. He is skilled in capital markets, M&A and funding startups and is a strong business development professional. For the past 30 years, he has created and managed numerous public and private companies in Canada, the U.S., Amsterdam, London, Zurich, Dusseldorf, Singapore and Panama. In addition to holding the role of chairman of the company, Eldridge is acting as a mentor to the team, assisting with the financials and structure of the company while allowing the team to be fully focused on Mobius’ growth and operations.


Investment Considerations

  • Mobius Interactive is an online gaming operator with a stable of three differentiated brands, which are set to simultaneously launch in September 2020.
  • The company’s management team has handled the launch of over 30 successful products within the last three years.
  • Mobius has partnered with award-winning iGaming platform Ultra Play to serve as the core technological backbone for its online gaming operations.
  • The company boasts a number of differentiating factors, including over 600 affiliate partners, deep management expertise within the eGaming segment and real-time CRM systems.
  • A partnership with Puurl is expected to allow Mobius to bring online gaming into the e-commerce space.
chart

Pac Roots Cannabis Corp. (CSE: PACR)

The QualityStocks Daily Newsletter would like to spotlight Pac Roots Cannabis Corp. (PACR).

Pac Roots Cannabis Corp. (CSE: PACR) was featured today in the 420 with CNW by CannabisNewsWire. Today’s cannabis market is experiencing significant growth in and demand for product diversity. At the same time, producers want reliable and stable plant varieties to ensure their products provide consistent quality. Advancements in breeding programs, artificial selection, genetics optimization and data analytics are helping cannabis producers meet both needs.

Pac Roots Cannabis Corp. (CSE: PACR) is a Canadian cannabis company dedicated to producing premium-quality strains and products by leveraging a genetics-focused approach.

The company began operations in 2012, with activities primarily directed toward exploration and development of mineral properties in Canada. Today, it is focused on cannabis and hemp cultivation, leveraging high-end genetics and specialized cultivars to produce top quality products. Pac Roots has announced multiple promising initiatives in recent months, including its formation of an outdoor premium hemp joint venture with partner Rock Creek Farms in British Columbia, Canada, and its agreement to acquire all issued and outstanding shares of a firm holding 250 acres of land in the famed Fraser Valley Region of British Columbia.

Pac Roots is also in the process of completing its 20,000 square foot cultivation facility in Lake Country, British Columbia. The facility is expected to feature approximately 7,600 square feet of cultivation space that will enable the company to cycle through an elite line of 350+ unique, high-grade cultivars. Pac Roots expects to receive a cultivation license for the facility in the fourth quarter of 2020.

High-End Selectively Bred Genetics

Pac Roots focuses on high-end genetics in order to maximize the quality of its products while maintaining high yields and profit margins.

Through the process of artificial selection, farmers and cultivators have been adapting their plants to develop particular phenotypic traits for generations. Historically, this practice was restricted to underground cannabis producers developing their own strains.

The legalization of the cannabis industry has given producers access to thousands of cultivars located throughout the world while accelerating research into cannabis genetics. By carefully selecting strains, growers can control the size, color, smell, density and texture of cannabis buds, thereby creating distinctive, premium cannabis products.

Plants are bred to thrive in specific growing environments. This maximizes the yield of high-quality, resilient cannabis. Medical cannabis strains can also be tailored for specific medicinal purposes.

A strategic partnership with Phenome One, a plant breeding management and analytics firm, gives Pac Roots access to some of the world’s best cannabis genetics from the largest genetic library in Canada. The company is using these genetics to develop unique strains featuring a variety of beneficial characteristics.

The company’s 350+ licensed live cultivars and over 1,800 seed varieties are the result of a meticulous gene selection process, through which as many as 600 individual plants may be grown to produce a single strain. Selecting optimized genetics in this way provides benefits beyond simply producing a high-end product. In addition to potency and bud quality, cannabis plants are bred for yield and resilience. By selecting genetics that result in larger and more numerous buds on each plant, Pac Roots is able to grow more cannabis per grow light.

Breeding plants to be more resilient also reduces the cost and labor required. These factors, combined with the premium price point associated with top-quality cannabis, have the potential to improve Pac Roots’ overall profit margin.

Partnership with Phenome One

Pac Roots has secured its cultivars through a strategic licensing agreement with Phenome One. Under the agreement, Pac Roots has unlimited access to Phenome One’s live genetic library, including any of Phenome One’s cultivars and its growing, breeding and cloning IP.

Phenome One is an agricultural technology company focused on providing software solutions to seed companies. Phenome One’s platform gives its partners access to a massive database of detailed information on over 350 unique cannabis cultivars to support each stage of the breeding process. Each cultivar has been laboratory analyzed and rigorously field-tested, with data going back more than 30 years.

Using Phenome One’s data, Pac Roots plans to grow a variety of cannabis plants optimized for certain traits. One such trait will be plants with an abundance of cannaflavin, a rare terpene with high anti-inflammatory properties. Phenome One’s library could enable Pac Roots to produce plants that are bred to thrive in a range of different growing climates, including plants suited to grow in cold weather and plants that are resilient to region-specific fungi.

Joint Venture with Rock Creek Farms of British Columbia

Pac Roots recently entered a definitive investment agreement with Rock Creek Farms, a reputable agricultural enterprise, for a 100-acre commercial hemp operation in Rock Creek, British Columbia. The growing space is located in the highly lucrative farming area known as the ‘Golden Mile’ in the South Okanagan Valley of British Columbia. (http://nnw.fm/Gbf9I).

Under the agreement, the two companies have formed an outdoor premium hemp joint venture company to which Pac Roots is providing an aggregate of $450,000 in capital and Rock Creek Farms is contributing two commercial leases for 100+ acres of growing space, along with cultivation licenses, agricultural infrastructure and equipment, consulting services, intellectual property relating to hemp operations and proprietary biomass storage methods. Pac Roots holds a 60 percent interest in the project.

About 127,500 premium hemp CBD seedlings were planted across 100 acres as of early July 2020. The joint venture is planting a premium grade CBD hemp variety utilizing the rich native soil and both traditional and custom farming techniques.

“Our operational partners at Rock Creek Farms bring decades of generational farming expertise in one of Canada’s pre-eminent growing regions,” Pac Roots President and CEO Patrick Elliott said in a news release detailing the venture. “It will be an exciting outdoor growing season for the joint venture as we anticipate a successful harvest in the fall.”

Infinite Development Possibilities at Fraser Valley Property in British Columbia

In mid-July 2020, the company initiated a share purchase agreement with 1088070 BC. LTD. (“1088”) and its shareholders for the acquisition of all issued and outstanding shares of 1088 (http://nnw.fm/xlpw7). Notably, 1088 owns and controls 250 acres of land spread over nine parcels in the Fraser Valley Regional District.

The Fraser Valley Regional District is one of the most productive and intensively farmed areas of Canada, offering access to high-quality soil, favorable climate, water and a local market of 2.5 million people. Agriculture in this region yields an annual economic value of more than $3 billion.

The closing date for the transaction is slated for September 4, 2020, after a 51-day due diligence period. According to Elliott, the addition of such a significant package of land is a major step for Pac Roots.

“This land has no zoning restrictions and is not situated within the agricultural land reserve, which provides for infinite development possibilities,” Elliott added in a July 2020 news release.

Board of Directors member Chad Clelland also welcomed the acquisition, adding that between Fraser Valley and Rock Creek – both of them among the most productive agricultural regions in Canada – Pac Roots is very well positioned for production and the future development of its hemp and cannabis infrastructure.

The RAD Americas Genetic Program – Research and Development in Americas Genetic Program

Pac Roots intends to deploy a global R&D program focused on rigorously testing elite strains in various rich agricultural regions throughout the Americas, with a goal of mass selection to achieve the utmost environmental resilience while achieving notable quality and yields. From seed to software, collection data, proprietary techniques and custom nutrient formulas, Pac Roots and Phenome will provide the specific knowledge to cultivators in different climates in order to achieve optimal yields for THC, CBD, CBG and other unique cannabinoids. R&D from global testing programs situated throughout the Americas will allow the partnership to deploy and stress test a range of suitable cultivars in the world’s lowest cost outdoor growing regions.

The company expects an industry shift in 2020 from the COVID-19 global pandemic. The ‘new normal’ will bring more focus on efficiencies and optimal yields to deliver a cost effective, high quality product to the end user. There has been much to be learnt from the inefficiencies in the cannabis industry in recent years, which have been detrimental to the credibility of the sector. Pac Roots is well positioned to enter the scene and take advantage of the deficiencies, reinforcing the notion that genetics and flawless growing techniques are paramount to success. Genetics and systems innovation may be the most overlooked components when comparing cannabis to other established agricultural crops. Pac Roots plans to invest into cannabis R&D to ensure a solid foundation is built that will be used by cannabis farmers worldwide.

Through its RAD Americas Development and Innovation, Pac Roots is focused on:

  • Deploying one of the largest live genetic libraries in Canada, diversified for high yield output and unique climates
  • Continued stress testing for indoor, high yield, THC and medicinal genetics
  • Continued stress testing for outdoor, high yield, THC and medicinal genetics
  • Exotic, genetic cloning for the luxury, high margin, cannabis flower market
  • Psychoactive/medicinal ratio testing for effect and
  • Unique Cannabinoid and terpene elevation and isolation.

Through its RAD Americas Field Testing System, the company is focused on:

  • Global testing in different microclimates to assess genetic and complete systems for optimal yields
  • Data collection, testing and optimization to prove process for commercial implementation and
  • High quality yield testing for THC, CBD, CBG and other unique medicinal cannabinoids.

Lake Country Cultivation Facility near Kelowna, British Columbia

Pac Roots is in the process of completing its 20,000 square foot cultivation facility in Lake Country, British Columbia. The facility is expected to feature approximately 7,600 square feet of cultivation space that will enable the company to cycle through its line of high-grade cultivars. Pac Roots plans to submit a video evidence package of the facility build under Health Canada’s Cannabis Tracking and Licensing System, and the company expects to acquire its cultivation license in the fourth quarter of 2020.

Lake Country is a municipality located just outside of Kelowna in the Okanagan region of British Columbia. For decades, the region’s favorable growing climate has made it a hub for cannabis cultivation. As the Canadian legal cannabis industry ramps up, the Okanagan region is attracting attention from dozens of cannabis companies, including some of the industry’s biggest names. The region’s strong agricultural history has left it rich with experienced agricultural workers and an abundance of Agricultural Land Reserve (ALR) property.

Management Team

Patrick Elliott, MSC, MBA, President and CEO of Pac Roots Cannabis, is also the President & CEO of Lexore Capital Corp., a private resource and cannabis investment company, as well as Phenome One Corp., a full-service cannabis farming company focused on elite strain selective breeding. Elliott brings over 15 years of corporate finance, mineral exploration and financial markets experience to the Pac Roots team. He is a graduate of the University of Western Ontario in geology and holds an MSc. in mineral economics and an MBA from Curtin University of Technology in Perth, Australia. Elliott specializes in economic resource evaluation, financial modeling, CAPEX estimation, corporate development and finance. Combined with his technical knowledge, Elliott has a wealth of contacts in the financial sector.

Marc Geen, Founder and Strategic Operations Advisor, is a fourth-generation British Columbia farmer who has been active in the legal medical marijuana industry for more than 10 years – consulting on, complying with, and participating in the MMAR, MMPR and ACMPR programs. Prior to co-founding Speakeasy Cannabis Club Ltd., Geen spent 14 years as Head of Operations for Kettle Mountain Ginseng Ltd., one of North America’s largest ginseng producers. With the experience gleaned from a long career in large scale commercial farming, Geen has been able to apply many cost-effective farming practices to the outdoor, indoor and greenhouse cultivation of cannabis. Geen is also the co-creator of a full line of cannabis extract products designed under ACMPR regulations.

Matt McGill, Director, has a strong background in both commercial and residential real estate and has played a major role in many development projects. McGill, through McGill Realty, has established a tremendous commercial and residential outfit servicing British Columbia’s Fraser Valley and the lower mainland. McGill is skilled at crafting strategic financing options for corporations and has a substantial network of retail and institutional clients.

Chad Clelland, Director, has experience in the sector dating back to 2009, when he purchased Medicalmarijuana.ca, which became an information portal for thousands of patients, doctors and growers. Through this company, he and his team have helped thousands of Canadians find legal, safe medication. His team also consulted, designed and submitted dozens of applications to the government under the MMPR, ACMPR and Cannabis Act. In 2011, Clelland co-founded Greenleaf Medical Clinic, which is now recognized as a training facility by the University of British Columbia and offers preceptorships to physicians, nurse practitioners and pharmacists. He also co-founded Folium Life Science in 2013, an approved Canadian Licensed Producer. His roles in these organizations have included Chief Operating Officer, head of security, alternate master grower and alternate responsible person in charge.

Josh Bromley, Senior Cultivation Strategist, is a second-generation farmer with over two decades of experience farming, breeding, cultivating and selecting unique cultivars for the medical community. He is an expert in plant science and possesses a comprehensive knowledge of cultivars and a mastery of medicinal implementation. Bromley has developed proprietary farming systems, as well as low cost/high output nutrient systems. Through thoughtful design and engineering, he has been able to consistently show improvements in crop yields, pathogen resiliency and quality.

Pac Roots Cannabis Corp. (PACR), closed Monday’s trading session at $0.30, even for the day. The average volume for the last 3 months is 57,511 and the stock's 52-week low/high is $0.11/$0.73.

Recent News

chart

LexaGene Holdings Inc. (TSXV: LXG) (OTCQB: LXXGF)

The QualityStocks Daily Newsletter would like to spotlight LexaGene Holdings Inc. (TSXV: LXG) (OTCQB: LXXGF).

LexaGene Holdings (TSX.V: LXG) (OTCQB: LXXGF), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, today announced that it has engaged LaunchWorks to support the commercial launch of MiQLab(TM) prior to the end of September 2020. “We are making great progress in adding sales and manufacturing to LexaGene’s capabilities. To view the full press release, visit http://ibn.fm/wvSu4.

LexaGene Holdings Inc. (TSXV: LXG) (OTCQB: LXXGF) is a molecular diagnostics company that develops genetic analyzers for rapid detection of pathogens at the point-of-need.

Based in the greater-Boston, Massachusetts area, the company’s fully automated genetic analyzer for pathogen detection, the MiQLabâ„¢, is designed to deliver reference-quality data with ease of use. MiQLab’s technology screens samples for up to 27 different targets at once—looking for pathogens and antimicrobial resistance factors—and returns results in approximately one hour. It is designed to be operated at the site of sample collection to avoid the delay associated with shipping and manually processing samples. This technology is designed for use in multiple markets, including human and veterinary diagnostics, as well as food safety testing ($12.9B, $2.2B, and $23.4B markets, respectively).

Portfolio Benefits

Rapid, automated pathogen detection

LexaGene’s MiQLab pathogen detection system offers rapid and sensitive testing to markets in need of better vigilance against pathogens that could endanger health and harm public safety and the bottom line. The company’s disruptive technology is on-demand and offers results in approximately an hour.

End users collect a sample, load it onto the MiQLab genetic analyzer with a sample preparation cartridge, enter a sample ID and press ‘go’.

MiQLab is open-access, which allows users to easily customize their own tests, in addition to running the company’s own validated tests. No comparable technology exists on the market today for automating customized testing. The open-access market is over $20 billion in value and includes industries like pharma and biotech that currently need an automated method of performing PCR testing in a cost-efficient way.

Improved COVID-19 Testing

As the COVID-19 pandemic continues to pose a threat to global safety, the need for improved testing procedures has been well established. LexaGene’s technology is automated and designed to be used at the point-of-need, thereby avoiding the 12- to 24-hour shipping time. Plus, it performs sample preparation and the gold standard RT-PCR chemistry for exceptional data quality in about one hour.

Because LexaGene’s open-access instrument can be rapidly configured to detect novel pathogens, it is ideally suited to prevent pandemic spread with its easily deployed testing that facilitates rapid quarantine-related decision making.

This speed is in stark contrast to competitor point-of-care technologies that have reagents pre-embedded into complex and expensive cartridges that are only manufactured at specialized production sites – making it impossible to rapidly meet a swift increase in demand.

According to Dr. Jack Regan, LexaGene’s CEO and founder, the world needs easy-to-use, fully automated pathogen detection instruments operating at points-of-need that can be equipped with tests to detect a novel pathogen within a week of knowing its genetic sequence. For this pandemic, the lack of such technology forced the majority of testing to occur in distant reference laboratories, making rapid decisions on quarantine impossible and making the likelihood of successful containment remote.

Regan explained in a press release (http://nnw.fm/Vz5Ju), “LexaGene expects to be the first company to commercialize an automated open-access microfluidic technology designed for use at the point-of-need that can be configured to detect a novel pathogen in just a week’s time of its emergence – for use on-site to return results in one hour – and improve our chances of successful containment.”

Market Potential

LexaGene’s technology has a wide range of applications across many other markets, including biotech and pharma testing, water quality monitoring, agricultural testing, biodefense, and use at point-of-need at border crossings, military bases, aircraft carriers and cruise ships.

Markets for customized testing solutions are poised for significant growth. Industry analysts forecast considerable expansion of many of LexaGene’s potential target markets in the coming years, including:

  • The genotyping sector, forecast to reach a valuation of $31.9 billion by 2023;
  • PCR assays, expected to make up a $7 billion market opportunity by 2026;
  • The sample prep market, forecast to eclipse $9.3 billion by 2025;
  • Water quality monitoring, set to grow to $1.59 billion by 2022; and
  • Agricultural testing, anticipated to reach $6.29 billion by 2022.

LexaGene’s patented microfluidic system was invented by company CEO Regan, a leading scientist who developed a bio-warfare surveillance instrument that has been adopted by the Department of Homeland Security. Regan is also known for developing an instrument that detects respiratory pathogens from nasal swab samples. The development of these instruments was supported by $20 million in government funding.

Management Team

LexaGene’s experienced leadership team drives company growth with a focus on innovation, pursuing unique market opportunities and providing shareholder value.

Dr. Jack Regan, Chief Executive Officer & Director, is the inventor of the company’s flagship automated pathogen detection technology, the MiQLab. Before founding LexaGene, he led a team of scientists at Bio-Rad Laboratories (NYSE: BIO) in developing tests for detecting pathogens, cancer and neurological disorders using droplet digital PCR. Prior to Bio-Rad, Regan helped QuantaLife, a startup company, bring its product from concept to commercialization, where it was subsequently acquired by Bio-Rad. He has also worked at Applied Biosystems/Life Technologies on automated sample preparation and did his post-doctoral training at Lawrence Livermore National Laboratory. His doctoral training at the University of California San Francisco focused on influenza viral replication.

Daryl Rebeck, President, has over 20 years of capital market experience with an established international financial network. Rebeck was a vice president and senior investment advisor with Canada’s largest independent investment bank, Canaccord Genuity, where he was responsible for raising significant risk capital for growth companies, with a particular focus on natural resources and medical technology. He has since worked to provide management expertise and grow shareholder value. He served as senior VP of corporate finance of Auryn Resources (NYSE: AUG), a $250 million market cap mining exploration company.

Jeffrey Mitchell, CFO, boasts over two decades of financial and SEC experience. Before joining LexaGene, he served as controller and director of finance, overseeing areas such as public company financial reporting, audits, and financial planning and analysis for Palomar Medical Technologies Inc. In addition to his many years at Palomar, Mitchell has served in numerous financial and strategic advisory roles for medical device, imaging and diagnostic companies.

LexaGene Holdings Inc. (TSXV: LXG) (OTCQB: LXXGF), closed Monday’s trading session at $0.701, up 0.142857%, on 515,762 volume with 254 trades. The average volume for the last 3 months is 344,950 and the stock's 52-week low/high is $0.303799986/$0.928245007.

Recent News

chart

DarioHealth Corp. (NASDAQ: DRIO)

The QualityStocks Daily Newsletter would like to spotlight DarioHealth Corp. (DRIO).

Aegis Capital Corp. has initiated coverage with a ‘Buy’ rating and price target of $25 on shares of DarioHealth’s (NASDAQ: DRIO) stock. DRIO is a pioneer in the global digital therapeutics (“DTx”) industry with its popular, smartphone-centered personalized chronic illness management software-as-a-service (SaaS). The report reads, “We initiate coverage on DRIO with a BUY rating and $25 PT based on a 5.6x EV/Sales multiple applied to FY:21E sales of $11.4mm, a discount to the est. peer average of 8.1x. We believe this multiple is warranted thanks to the growth prospects and quality of the product offering, underpinned by published efficacy data, with a modest discount for conservatism. At 6/30, Dario had $13.2mm of cash, and on 7/31, a further $28.6mm in gross proceeds were raised through a private placement.”

New York and Israel-based DarioHealth Corp. (NASDAQ: DRIO) leads global digital therapeutics (DTx) with its popular, smartphone-centered personalized chronic illness management software-as-a-service (SaaS). The company’s strategic advantages include:

  • AI-powered digital solutions that drive durable behavior change in chronic disease patients, and
  • Personalized user experience at scale to make behavior change the path of least resistance.

Approximately $3 trillion in annual U.S. costs associated with chronic illnesses like diabetes, hypertension and obesity are largely preventable with behavioral therapies. Formerly limited to periodic office visits, these therapies can now scale to millions with tech-enabled, continual and remote health monitoring, as well as AI-driven digital and live coaching. This is all possible while still maintaining the personalization required for success in reducing illness and its related effects and costs.

Roughly 51,000 active, paying users manage their health with Dario’s platform that combines smartphone-connected vitals measurement, remote patient monitoring (RPM), lifestyle management tools, and AI-driven and human coaching to deliver improved clinical outcomes.

Among the most downloaded medical apps, the Dario platform is rated at 4.9 stars on the Apple App Store and features 11,000 reviews, along with a Net Promoter Score (a measurement of consumers’ willingness to recommend the product to others) that’s the highest in its field.

Company Strategy

Clinical studies demonstrate Dario’s direct improvement on users’ health measures like H1AC scores (diabetes) and blood pressure (hypertension).

Patient engagement in therapies leads to health success. Dario’s platform centers on continual maximization of patient engagement through personalization, including ‘nudges’ and live, AI-generated responses to health measures provided by Dario’s smartphone-connected medical devices.

Proprietary data analysis provides valuable insights that not only improve health care providers’ medical capabilities but, through artificial intelligence, encourage patients to take evidence-based and highly personalized preventative measures that reduce risk, emergency room visits and preventable hospitalization.

Dario is now deploying its successful B2C platform in B2B2C, targeting employers and health plans with competitive advantages in cost, software and hardware.

The company estimates an annual addressable U.S. market of $72 billion, only 1% of which has been penetrated with digital therapeutics.

The strategic transition to B2B2C (from exclusively B2B) is intended to accelerate revenue growth by reducing Dario’s cost per acquisition per user and expanding margins.

Dario’s commitment to aggressive growth is also shown by its appointment of a new president, chief medical officer and head of sales for North America, all from a highflyer behavioral health company.

Key growth drivers planned include expansion of the company’s paying B2C subscriber base; lateral expansion into other chronic conditions that overlap with its core diabetes populations, such as hypertension, obesity and depression; and increased B2B2C penetration.

Financial Highlights

The company plans to leverage a massive opportunity for growth, with a global addressable market for digital therapeutics of roughly $108 billion. In the U.S. alone, that number is estimated at $72 billion, and only about 1% of that market has been penetrated.

Dario’s strategic transition to an SaaS membership business model increased gross profit by 87% in Q1 2020, as compared to the prior year. Membership revenue increased from 27.1% to 46.7% in the same period. The company is seeing improved operating efficiencies as it shifts focus to the B2B2C business model, and it expects average revenue per user per month (ARPU), which was $6 and $25 in 2019 and 2020, respectively, to reach $70.

Value to Consumers and Businesses

Dario continually evaluates and optimizes the value and return its platform delivers to consumers and businesses.

Consumers seeking to understand how their everyday behavior impacts their personal health and chronic conditions benefit from actionable feedback on how to improve health and better collaborate with health care providers.

Businesses looking to increase employee satisfaction, loyalty and productivity with fewer health-related absences take advantage of Dario’s services for employers.

Health care providers improve patient compliance using the platform’s interactive services that allow for greater monitoring, which improve engagement with patients at the right times and with the right treatments.

Health plans can leverage DarioHealth’s solutions to improve patient outcomes and lower costs.

Recent Studies

The company recently presented the results of two new studies at the American Diabetes Association’s 80th Scientific Sessions, which showed sustained improvements in blood glucose levels and blood pressure among users of its digital therapeutic platform for chronic diseases. The results of these two studies demonstrate that the use of Dario’s therapeutic platform promotes behavioral modification, enhanced individual engagement and improved clinical outcomes.

Remote Patient Monitoring (RPM) Agreements

The Centers for Medicare & Medicaid Services recently approved RPM codes for Medicare patients, which enables physicians to bill for between-visit patient care.

This simplifies implementation of the company’s open and scalable AI-driven platform and further supports transition to the company’s high-margin, recurring SaaS model targeting B2B2C revenue channels.

Emergency COVID-19 FDA Guidelines Allow Self-Test Blood Glucose Meters

In an effort to preserve personal protective equipment (PPE) and reduce contact between health care providers and patients in hospital settings due to COVID-19, the U.S. Food and Drug Administration (FDA) has recognized that home-use blood glucose meters, including Dario’s smartphone-connected metering device, may be used by patients with diabetes who are hospitalized due to COVID-19 to check their own blood glucose levels and provide the readings to the health care personnel caring for them.

As a result, hospitals can now allow patients to self-test using their Dario blood glucose testing strips and smartphone-connected devices, or hospitals can issue patients Dario devices upon admission for COVID-19-related conditions.

Irregularities in blood glucose levels are suspected as a factor in the increased severity of potentially deadly COVID-19 complications. As such, a high priority is being placed on stabilization of patients’ blood glucose levels.

Awards and Recognition

DarioHealth’s Blood Glucose Monitoring System was voted as the ‘Best Glucometer for Data Management’ by Top Ten Reviews. Jeph Preece, senior editor at Top Ten Reviews, said, “The Dario app is the best data management system that I’ve seen. Compared to apps by popular brands, Dario’s system looks and feels like it’s years ahead of the curve.”

‘The Global Digital Health 100’, an annual award sponsored by the reputable Journal of Health, recognized DarioHealth as a leader among health technology companies demonstrating the greatest potential to change the way that health care is delivered.

DarioHealth Corp. (DRIO), closed Monday’s trading session at $18.68, up 13.2121%, on 263,741 volume with 1,529 trades. The average volume for the last 3 months is 235,276 and the stock's 52-week low/high is $3.01999998/$18.834999.

Recent News

chart

SRAX Inc. (NASDAQ: SRAX)

The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

SRAX (NASDAQ: SRAX), a financial technology company, this morning announced financial results for the three months ended June 30, 2020. Among other highlights, SRAX reported total revenue of $1,165,000 for Q2 2020, representing an increase of 232% from Q1 2020. To view the full press release, visit http://nnw.fm/lBnkD

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.

BIGtoken

BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.

Leadership

Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Monday’s trading session at $2.83, off by 4.0678%, on 311,883 volume with 1,017 trades. The average volume for the last 3 months is 80,492 and the stock's 52-week low/high is $1.04999995/$3.50.

Recent News

chart

Cannabis Global Inc. (CBGL)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Global, Inc. (CBGL).

Cannabis Global Inc. (OTC: CBGL) was featured today in the 420 with CNW by CannabisNewsWire. As more and more states legalize the consumption of cannabis for medicinal and recreational use, innovation and technology are also adding to the growth of the industry. In today’s world of big data, every cannabis business must efficiently harness the power within its data about consumers, individual products and sales. Both dispensaries and growers are leveraging data analytics to track products and ensure compliance with various state mandated regulations.

Cannabis Global Inc. (CBGL) is an innovator in the field of cannabinoid nanoparticles and infusion technologies with several important cannabinoid patents filed and an active research and development program underway. The company was reorganized during June 2019 and announced its intent to enter the cannabis sector. In August 2020, it changed its corporate identity from MCTC Holdings Inc. to Cannabis Global Inc. The company is headquartered in Los Angeles, California.

With the hemp and cannabis industries rapidly expanding in terms of market size, acceptance and number of market participants, CBGL plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company is actively pursuing R&D programs and productization of advanced cannabinoid delivery systems, based on solid polymeric nanoparticles and fibers. These technologies hold the promise to revolutionize the science of cannabinoid bio-enhancement for use in foods, beverages, consumer products and in transdermal applications. Because of nanoparticles’ ability to be quickly absorbed into the bloodstream, nanotechnology has been utilized in the food and drug industry for some time and has the potential for tremendous growth in the cannabis industry (http://nnw.fm/v6RQ6).

Cutting-Edge Technology

CBGL is at the cutting-edge of the cannabis industry’s trends with its emphasis on polymeric nanotechnology. This is not to be confused with the more basic oil-in-water nano-emulsions currently marketed to the food and beverage industry. The company’s polymer-based particles offer significant loading of active ingredients and unmatched flexibility and customization, allowing for myriad combinations of cannabinoids with unique performance characteristics. CBGL believes polymeric nanotechnology particles will be a critical technology area for the cannabinoid formulation marketplace.

The company continues to build its R&D program, specifically researching the development of improving methods to make cannabinoids available to living systems. Instrumental in the research program is the development of novel polymeric nanoparticles and nanofibers. These have the potential to elevate the potential of cannabinoid products in the following ways (http://nnw.fm/cK3Bl):

  • Significantly improving bioavailability
  • Allowing for ultra-high loading rates
  • Enhancing customization of cannabinoid combinations
  • Improved dosing precision
  • Providing more control in release parameters

CBGL leadership understands the importance of developing intellectual property (IP) in the ever-evolving cannabis industry. A recent Forbes article described IP as “critical for creating true differentiation between companies and their product and service offerings” (http://nnw.fm/57Fjh). Recognizing the importance of IP, CBGL has been consistent in its application for patents to protect its innovative nanotechnology applications.

Patents

CBGL has now filed four patents on its cannabinoid delivery technology systems:

  • The company first collaborated with Cannabis Nanosciences Inc. on technologies. This became the basis for its first patent filing on an innovative edible dissolvable film for cannabinoid ingestion.
  • Its second patent filing for cannabinoid nanoparticles combined TPGS, a water-soluble form of vitamin E.
  • Its third patent filing involved a unique 4th dimension, 3D printed cannabinoid delivery system for beverages.
  • Its fourth patent, considered its most significant, broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially within a water-soluble medium.

Collaborations

CBGL collaborated with Marijuana Company Inc. (OTCQB: MCOA) subsidiary hempSmart Inc., under a hemp extract and CBD product supply agreement wherein hempSmart will utilize its extensive network of marketing partners to market CBGL’s powered drink mixes and other CBD edibles online. These products are designed for the dry beverage and edibles sector and will be supplied by CBGL. They incorporate the company’s patent-pending cannabinoid infusion technologies and will be trademarked as Hemp You Can Feel (TM) and Gummies You Can Feel (TM).

Leadership

CBGL CEO and chairman Arman Tabatabaei boasts 15 years of management and operations experience and is considered an expert at data collection and analysis relative to resource management, risk forecasting, and profit and loss management. He has acted as a consultant with Cannabis Strategic Ventures (OTCQB: NUGS) and played an instrumental role in improving operations at Sugarmade Inc. (OTCQB: SGMD) relative to the company’s hydroponic growth supplies initiatives.

CBGL founder and director Robert Hymers also brings a seasoned perspective, having had significant experiences in the cannabis industry and as a financial executive and consultant. He is the managing partner of Pinnacle Tax Services in Los Angeles and was previously CFO and director of Marijuana Company of America Inc. (OTC: MCOA). He is currently a member of the Strategic Advisory Board at Massroots Inc. and acts as a consultant to both Cannabis Strategic Ventures Inc. and Sugarmade Inc. Hymers’ background in tax accounting, auditing, SEC reporting, mergers and acquisitions, and corporate finance has immense value in his current position at Cannabis Global.

Cannabis Global, Inc. (CBGL), closed Monday’s trading session at $0.175, up 9.375%, on 107,491 volume with 35 trades. The stock's 52-week low/high is $0.05/$3.00.

Recent News

chart

Jerrick Media Holdings, Inc. (JMDA)

The QualityStocks Daily Newsletter would like to spotlight Jerrick Media Holdings, Inc. (JMDAD).

Jerrick Media Holdings (OTCQB: JMDA, JMDAD), a technology company and the parent company of Vocal, today announced financial results for the quarter ending June 30, 2020, including a substantial increase in revenues year over year and a 10% increase from the previous quarter. Among other highlights, the update reported an increase in revenue to $322,540 for the three months ended June 30, 2020, primarily attributable to the launch and steady growth of Vocal+ paid subscribers and the rising price points for Vocal for Brands campaigns. To view the full press release, visit http://nnw.fm/fAFSX

Jerrick Media Holdings, Inc. (OTC: JMDAD) develops technology-based solutions to solve digital problems. Through the combination of design, thought and data analysis, the company builds products that influence a worldwide audience.

Jerrick’s flagship product is Vocal, a proprietary long-form digital publishing platform that provides storytelling tools and engaged communities for creators to get discovered and fund their creativity.

Vocal

Designed to develop and cost-effectively engage content creators, the Vocal platform enables its over 500,000 registered content creators to reach an engaged audience and monetize their content. In addition to providing relevant content, Vocal’s technology is centered on efficiency and scalability through its niche digital communities, as well as output through its data-driven distribution strategy.

Vocal partners with content creators and brands that recognize difficulties inherent in the digital advertising space and that can benefit from branded content marketing opportunities available on publishing platforms like Vocal.

All content available on Vocal is created within the platform’s custom editor and published on one of Vocal’s embedded genre-specific communities, spanning topics that range from food to wellness, beauty, technology and more.

In May 2019, Jerrick launched Vocal+, its premium subscription membership program. Vocal+ members pay a membership fee for premium value-added features, including receiving increased earnings for their content, reduced platform processing fees for tips received, a Vocal+ badge on their creator page, access to new features on the Vocal Platform, and other rewards. Creators can sign up for free or upgrade to Vocal+, available for purchase on either an annual or monthly subscription basis.

 

Vocal for Brands

Vocal for Brands is an in-house creative studio that generates actionable data from bespoke native advertising campaigns. Vocal for Brands partners with direct-to-consumer (DTC) to create beautiful, campaign-optimized stories on Vocal that build brand affinity, trust and drive results.

Additionally, Jerrick provides a Managed Services offering to business-to-business (B2B) and business-to-consumer (B2C) product and service brands which encompasses a full range of digital marketing and e-commerce solutions. Managed Services includes the setup and ongoing maintenance of clients’ websites, Amazon and Shopify storefronts and listings, social media pages, search engine marketing, and other various tools and sales channels utilized by e-commerce sellers for sales and growth optimization. In addition to partnering with Managed Services clients, the company offers a range of la carte services.

Growth Strategy

Upon the consummation of its anticipated listing on the Nasdaq Capital Market, Jerrick intends to change its official company name to “Creatd, Inc.,” subject to stockholder approval.

This rebranding will initiate Jerrick’s go-forward growth strategy and its plans to expand its offerings and provide technology products and resources for creators to help transform their ideas into reality. The strategic plan is designed to greatly increase Jerrick’s potential market value via a plethora of new revenue streams.

Creatd will focus on a community of creators that number more than 2.5 billion users, for which it will offer democratized, transparent platforms for distribution, sentiment, resources and monetization. The company’s agile development process will rely on a combination of bleeding-edge technology that eliminates barriers and creates efficiencies. Superior design thinking and data analysis will allow Creatd to expand its digital footprint to a global community.

Creatd will partner with a community of technology collaborators and sophisticated investors who collaborate to provide technology solutions for creators, brands and their respective audiences. The company’s solutions, business processes, technology platforms and design theories will lend themselves to application opportunities on a global scale.

History & Management

Jerrick was founded in 2012. Initially a private media company providing online content through a portfolio of brands, Jerrick’s needs quickly outpaced its initial technology and product offering. In 2015, Jerrick partnered with Thinkmill, a premiere, Australia-based product design and development group to create a content management system (CMS) for its brands; that system evolved into the company’s flagship product, Vocal.

Today, Jerrick’s management team is an impressive group of abstract thinkers united by their passion to solve problems. Leading the team are founder and CEO Jeremy Frommer, and Justin Maury, Jerrick’s president and head of product.

Frommer’s career includes two decades in the financial technology industry, working as a hedge fund and portfolio manager, as well as on the sell-side of the financial industry. Frommer started NextGen Trading, a software development company building proprietary equity trading platforms. NextGen was acquired by Carlin Financial Group of which Frommer became CEO. RBC Capital Markets Corporation eventually bought Carlin. At RBC, Frommer was managing director, head of the Global Prime Services group and a member of the RBC Global Equities Operating Committee.

Maury joined Jerrick in 2013, bringing with him 10 years of experience in the creative industry. Since partnering with Frommer to establish Jerrick, Maury led the company’s product development for more than four years. His passion for the creative arts and technology ultimately yielded the vision for Vocal. During the Jerrick’s early formative years, Maury was a driving force in creating the vision, design and architecture for the Vocal platform and managing the oversight of technology development.

Jerrick Media Holdings, Inc. (JMDAD), closed Monday’s trading session at $8.205, up 200.00%, on 25 volume. The stock's 52-week low/high is $6.36000013/$19.4099998.

Recent News

chart

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT)

The QualityStocks Daily Newsletter would like to spotlight Blue Hat Interactive Entertainment Technology (BHAT).

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of augmented reality (“AR”) interactive entertainment games, toys and educational materials in China, on Friday released its unaudited financial results for the six months ended June 30, 2020. Among other highlights, the company reported total revenues of $4.9 million and gross profits of $3.7 million for the period. To view the full press release, visit http://nnw.fm/iNJqX

Blue Hat Interactive Entertainment Technology (BHAT) is a cutting-edge creator, developer and operator of popular augmented reality (“AR”) interactive smart toys and educational games in China. Blue Hat’s mobile-connected entertainment platform connects physical items to mobile devices through wireless technologies, creating a unique interactive user experience in various mobile games, interactive educational materials and toys with mobile game features.

Blue Hat designs original toys and games that utilize augmented reality technology, motion capture technology, image recognition technology, voice control, light sense technology, infrared, levitation induction, and other trending scientific technologies to transverse the virtual with reality. Blue Hat creates a rich visual and interactive environment for users through the integration of real objects and virtual scenery. This combination provides users with a more natural form of human computer interaction, enhances a user’s perception of reality, and delivers a more immersive entertainment experience.

Proprietary Technology

Founded in 2010, Blue Hat’s proprietary technology, product research and development, marketing channels and brand operation are the cornerstones of the business. Blue Hat focuses on the combination of “online” and “offline” activity and the interaction between “entertainment” and “product” to create a high-tech entertainment platform combining mobile games and AR. With the help of computer graphics, motion capture technology, image recognition technology and visualization technologies, Blue Hat accurately “places” virtual objects into the physical world, creating a new and stimulating visual environment for users.

Blue Hat recently displayed a variety of its sci-tech products at the Guangzhou International Toy Exhibition in China including AR Racer, Elastic Bubbles, AR Space Track, AR Alloy Toy Car, AR Need a Spanking, 5D Animated Magic Aquarium, Bug Travelers, AR Picture Book and other interactive games and smart toys.

The company has multiple products in development including new generations of four primary product lines and two new product lines.

Patents and Copyrights

Blue Hat’s advanced AR technology in interactive entertainment is protected by 178 authorized patents with 44 patents in various stages of the application process.

Another 14 applications for Patent Cooperation Treaty, or PCT, have been filed for international patents. As of March 31, 2019, the company owns 645 copyrights for artwork, 71 registered trademarks and 27 software copyrights.

Sales and Marketing

There has been rapid growth in the toys and games industry in China over the last several years. Total retail sales of toys and games in China soared from RMB 111.8 billion in 2012 to RMB 276.5 billion in 2017 with an average annual growth rate of 19.9% in 2017. Blue Hat believes the company is well positioned with little competition as the toy industry rapidly shifts toward intelligent and interactive toys and games. Retail sales of electronic toys grew at 24% annually in 2017 while that of traditional toys grew at 7%.

In addition to a powerful ecommerce presence, Blue Hat has long-term relationships with partnered distributors that place the company’s AR interactive entertainment products into well-known international retail chains and retail outlets. Blue Hat’s integrated online and offline sales channels include e-commerce giants such as Amazon and Alibaba, retail chain stores and the company’s physical experience store located in Xiamen, China. Blue Hat plans to open or franchise approximately 100 additional stores in China by 2021.

Blue Hat’s community-based platform offers users a highly engaged and interactive community with online communication forums and offline social activities. The company advocates a new model of “teaching through lively activities” and combines AR technology with education, integrating its products into situational teaching, roleplaying and man-machine interaction. This novel educational experience helps realize optimal transformation of information, creating a knowledge and enhancing cognition.

Management

Director and CEO Xiaodong (Sean) Chen has over 20 years of experience creating, developing and producing toys and games related products. Chen earned his EMBA from Renmin University of China and has been chairman of the board of directors and general manager of Fujian Blue Hat Interactive Entertainment Technology Ltd. since August 2015.

CFO and Director Caifan, who has over 20 years of financial accounting and taxation experience, earned a degree in finance from Hunan University of Finance and Economics. He has served as director, deputy general manager and financial controller of Fujian Blue Hat Interactive Entertainment Technology Ltd. since August 2015.

Jianyong Cai, chief technology officer and director, has over 35 years of experience in data communication principles, communication network foundation, software engineering, communication network theory and technology and computer network architecture. He holds degrees in data communication principles, communication network foundation and software engineering from University of Science and Technology of China. He has been director, deputy general manager and chief engineer of Fujian Blue Hat Interactive Entertainment Technology Ltd. since January 2010.

Blue Hat Interactive Entertainment Technology (BHAT), closed Monday’s trading session at $0.9322, off by 18.9391%, on 1,926,028 volume with 2,907 trades. The average volume for the last 3 months is 1,652,692 and the stock's 52-week low/high is $0.630800008/$3.75.

Recent News

chart

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)

The QualityStocks Daily Newsletter would like to spotlight Foresight Autonomous Holdings Ltd. (FRSX).

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, today announced its , Chief Financial Officer, Eli Yoresh, and Vice President of Business Development, Doron Cohadier, will present virtually at the LD Micro 500 Virtual Conference at 12:00 p.m. EDT on Tuesday, September 1, 2020. To view the full press release, visit http://nnw.fm/L1v7i

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.

Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.

The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.

Foresight has developed three main products:

  • QuadSightâ„¢. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSightâ„¢ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
  • Eyes-Onâ„¢. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
  • Eye-Netâ„¢. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Netâ„¢ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Netâ„¢ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.

In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.

Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.

Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.

Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.

Foresight Autonomous Holdings Ltd. (FRSX), closed Monday’s trading session at $1.19, off by 0.833333%, on 1,086,171 volume with 2,980 trades. The average volume for the last 3 months is 5,306,638 and the stock's 52-week low/high is $0.460999995/$1.95000004.

Recent News

chart

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF)

The QualityStocks Daily Newsletter would like to spotlight Siyata Mobile Inc. (SYATF).

Siyata Mobile (TSX.V: SIM) (OTCQX: SYATF), a provider of next-generation push-to-talk over cellular (“PTT”) devices and cellular booster systems, today announced its appointment of Nicholas Yaeger as VP of Sales for the company’s Verizon account, effective immediately. Yaeger is an experienced individual with an extensive background in the telecommunications industry and has served in various roles and departments at Verizon for more than 15 years. To view the full press release, visit http://nnw.fm/iQNRG

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) is a leading global developer and provider of Push-to-Talk Over Cellular ("PTT/PoC") systems for enterprise customers. The company specializes in connected vehicle products for professional fleets and markets its products under the Uniden® Cellular brand.

Since its inception in 2012, Siyata has amassed a customer base that includes cellular operators, commercial vehicle technology distributors, and fleets of all sizes in Canada, the U.S., Europe, Australia and the Middle East.

Recognized by the Toronto Venture Stock Exchange in 2018 as a Venture Top 50 Company, Siyata aims to deliver the highest quality and most technologically advanced mobile communication devices for global corporate workforces, fleets, homes and buildings.

The company has long been an industry pioneer, delivering the world's first 3G connected vehicle device as well as the world's first 4G/LTE vehicle mounted smartphone for First Responders and commercial fleets and vehicles.

Siyata is headquartered in Montréal, Québec, Canada.

Product Portfolio

Siyata's suite of technology includes numerous PTT and legacy devices, as well as cellular boosters designed to improve cellular signals in corporate warehouses, government embassies, retirement home campuses, banks and manufacturing plants.

The company's flagship product, the Uniden UV350, is the world's first vehicle-mounted 4G/LTE smartphone with crystal clear quality, carrier grade PTT, voice, text, video and data applications built into a single device. Specifically designed for First Responder and commercial fleet vehicles, the UV350 runs on cellular LTE networks that provide nationwide and global coverage, replacing traditional single purpose two-way radios that require a monthly fee and limited network coverage.

The Uniden UV350 is currently available through Bell Mobility, Canada's largest LTE network and PTT community. Expanding its availability, Siyata is completing network approval with two North American Tier 1 operators to launch the UV350 in the U.S. in 2019.

Management Team

CEO and Chairman Marc Seelenfreund is the founder of Siyata. He is also the founder of Siyata's parent company, Accel Telecom, an Israel-based company that specializes in importing and distributing innovative cellular and IP devices to fixed line operators and mobile providers within Israel. Prior to establishing Accel, Seelenfreund was a vice president at Sunrise Corporation in New York where he focused on financing publicly traded technology companies. Seelenfreund has a law degree from Bar Ilan University, is a board member at Israel's leading private university, and has served as an officer in the Israel Defense Forces.

Glenn Kennedy, vice president of sales, has over 25 years of sales experience in the telecommunications industry. Prior to joining Siyata in 2016, Kennedy managed sales nationally for Motorola Canada, HTC Communications Canada, and Sonim Technologies. He holds a bachelor's degree in honors business administration from the Richard Ivey School of Business at the University of Western Ontario.

CFO Gerald Bernstein, a professional chartered accountant, has spent 20 years focusing on private equity financing and tax efficient corporate structuring in multi-jurisdictional arenas. He holds a bachelor's degree of commerce as well as a graduate diploma in public accountancy from McGill University. Bernstein has been a member of the Canadian Institute of Chartered Accountants since 1987.

Gidi Bracha, Vice President of Technology, has served in this position since 2011 and spearheaded the development of both the Truckfone, Voyager and UV350. Bracha served in various key positions at Cellcom, Israel's leading cellular provider, including head of car mobility products and director of type approvals. Bracha served as an engineer technician in the Anti-Aircraft division of the Air Force in the Israel Defense Forces and holds a bachelor's degree in engineering and business management from the University of Derby.

Siyata Mobile Inc. (SYATF), closed Monday’s trading session at $0.0711, up 0.851064%, on 86,820 volume with 13 trades. The average volume for the last 3 months is 186,001 and the stock's 52-week low/high is $0.061999998/$0.356400012.

Recent News

chart

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed Monday’s trading session at $2.35, up 11.9048%, on 58,480 volume with 112 trades. The average volume for the last 3 months is 18,025 and the stock's 52-week low/high is $0.600600004/$4.48999977.

Recent News

chart

Bullfrog Gold Corp. (CSE: BFG) (OTCQB: BFGC) (FSE: 11B)

The QualityStocks Daily Newsletter would like to spotlight Bullfrog Gold Corp. (CSE: BFG) (OTCQB: BFGC) (FSE: 11B).

Bullfrog Gold Corp. (the “Company”) (CSE: BFG) (OTCQB: BFGC) (FSE: 11B) is a Delaware corporation engaged in the acquisition, exploration and development of gold and silver properties in the United States. The Company controls strategic lands with established 43-101 compliant resources in one of the most exciting gold exploration areas in the United States. The Bullfrog Gold Project (“Project”) includes a lease/option on much of the lands where Barrick Bullfrog Inc., a subsidiary of Barrick Gold Corp., produced more than 2.3 million ounces of gold and 2.49 million ounces of silver from 1989 to 1999. The Project is located within the prolific Walker Trend about 125 miles northwest of Las Vegas, Nevada.

Project Highlights

  • The Company initially acquired 79 unpatented claims and two patents in mid-2011 and has since staked, leased, optioned, or purchased lands that now total 5,250 acres. Via a 2015 lease/option with Barrick, the Project includes the northern one-third of the Bullfrog deposit where most of the current resources in the Bullfrog mine area occur, along with their interest in the Montgomery-Shoshone deposit which gave the Company 100% control.
  • In mid-2017, a NI 43-101-compliant report by independent mining consultancy Tetra Tech Inc. estimated measured and indicated (“M&I”) resources of 624,000 ounces of gold and 1.73 million ounces of silver at average grades of 0.70 g/t and 1.93 g/t, respectively. The expansion plans of these two pits were based on a $1200 gold price, use of heap leach processing, and also included 110,000 ounces of inferred gold resources averaging 1.20 g/t. Barrick used conventional milling to process an average gold grade of 3 g/t.
  • The established resources and exploration potential of the Project are strongly supported by a large data base obtained from Barrick, including detailed information on 155 miles of drilling in 1,262 holes in the Bullfrog mine area.

Gold Rush in the Bullfrog Territory

The area around Beatty, Nevada has now attracted AngloGold Ashanti, Kinross Gold, Corvus Gold, Coeur Mining as well as the Company and Waterton. In this regard, Northern Empire Resources Corp’s property located a few miles east of the Project was acquired by Coeur Mining in October 2018 for C$117 million, implying a valuation of C$134/oz of inferred resources. As of today, the Company is trading at a significant discount to the valuation at which Northern Empire was purchased (http://nnw.fm/9NaaN), thereby highlighting the Company’s value proposition for investors.

Bullfrog Gold Corp. is focused on enhancing shareholder returns by concurrently advancing Project development and performing exploration drilling programs on several targets identified by the Company.

Secured Financing for 2020 Operations

Bullfrog Gold Corp. raised C$2 million in January 2020 through a private placement of shares priced at C$0.13/share plus a one-half warrant exercisable within two years at C$0.20 on a full warrant basis. The raise was carried out primarily to fund a drill program that started on May 1 (http://nnw.fm/6nZ0m), and was completed on June 6, 2020. Results from drilling 12,520 feet in 25 holes will be released in the coming weeks. The Company subsequently intends to conduct a preliminary financial analysis and complete further drill programs to advance the Project and add value. The financing was subscribed by several influential shareholders, including a former director of Northern Empire, who handled the sale of the company to Coeur Mining, and Eros Resources, the management of which has been involved with several high-profile mining projects and sales in the past.

Gold Prices estimated to average $1,800/oz in 2021

Gold prices have been on a remarkable run in 2020, rising by $245/oz to $1,760 prior to peaking in early May. Global central banks carried out 144 interest rate cuts thus far in 2020, reducing their rates by a cumulative 5,035 basis points (http://nnw.fm/jzZt0). Meanwhile, the IMF has estimated that global governments have introduced fiscal support measures amounting to over $9 trillion since the start of the COVID-19 pandemic (http://nnw.fm/Or9rI). The resulting weakness in the U.S. dollar and eventual inflationary pressures stemming from these measures prompted Credit Suisse to recently hike their gold price forecasts for the full year to $1,701/oz (from $1,570 previously), while the outlook for 2021 has been raised to $1,800/oz (versus $1,600 previously) (http://nnw.fm/Iqg0X).

Management Team

David Beling, CEO, President and Director
David Beling is a Registered Professional Mining Engineer with 55 years of diverse experience in areas such as engineering, development, permitting, construction, financing and management of mines and plants and the building and growth of several corporations. His initial employment included 14 years with Phelps Dodge, Union Oil, Fluor, United Technologies, and Westinghouse, followed by 41 years of senior management and consulting with 25+ U.S. and Canadian mining companies. In 2006-2007, he spearheaded an IPO, successfully drove equity raises totaling C$112 million and grew that Company’s market capitalization to $460 million. Beling has served on 14 boards since 1981, including three mining companies distinguished by the TSX Venture Exchange as top-10 performers.

Alan Lindsay, Chairman of the Board
Alan Lindsay is an entrepreneur and businessman who has founded seven companies within the mining and pharmaceutical industries, including Anatolia Minerals Development Ltd., Uranium Energy Corp., Oroperu Mineral, Strategic American Oil and AZCO Mining. Lindsay also developed the strategic vision for the 2011 acquisition and placement of the Project from NPX Metals into Bullfrog Gold Corp.

Kjeld Thygesen, Director
Kjeld is a graduate of the University of Natal in South Africa and has 48 years of experience as a resource analyst and fund manager. In 1972, he joined James Capel and Co. in London as part of its highly rated gold and mining research team before subsequently becoming manager of N. M. Rothschild & Sons’ commodities and Natural Resources Department in 1979. In 1987, he became an executive director of N. M. Rothschild International Asset Management Ltd., before co-founding Lion Resource Management Ltd., a specialist investment manager in the mining and natural resources sector, in 1989. Thygesen has been a director of Ivanhoe Mines Ltd. since 2001 and served as investment director for Resources Investment Trust PLC from 2002 to 2006.

Tyler Minnick, CFO and Director of Administration & Finance
A registered member of the Colorado Society of Certified Public Accountants with over 24 years of experience within the fields of accounting, auditing, and administrative services. Minnick has been engaged with the Company since mid-2011 and previously worked in the finance department of MDC Holdings/Richmond American Homes, one of the largest residential construction companies in the United States.

Bullfrog Gold Corp. (OTCQB: BFGC), closed Monday’s trading session at $0.1625, up 5.9322%, on 584,869 volume with 109 trades. The average volume for the last 3 months is 231,141 and the stock's 52-week low/high is $0.047449998/$0.209999993.

Recent News

chart

Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

On June 15, 2020, Net Element announced its entry into a binding letter of intent to merge with privately-held Mullen Technologies Inc., a Southern California-based electric vehicle company, in a stock-for-stock reverse merger in which Mullen’s stockholders will receive the majority of the outstanding stock in the post-merger company. The proposed merger is currently pending the execution of a definitive agreement, shareholder vote and regulatory approval.

Net Element Inc. (NASDAQ: NETE) is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce and mobile devices. The company operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. The company’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

Net Element has also launched a blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element chairman and CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked on Deloitte’s Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies in both 2017 and 2018, during which the company grew 190 percent and 183 percent, respectively. The company credits its progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

Net Element was also listed among South Florida Business Journal’s 2016 fastest growing technology companies.

Leveraging its suite of application performing interfaces (APIs) and connectors, Net Element powers commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Leading this innovation is chairman and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jeffrey Ginsburg, CPA, and Steven Wolberg, the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations like Aptito to e-commerce and retail payment transaction processing brands like Payonline and Unified Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed Monday’s trading session at $9.42, off by 1.1542%, on 401,848 volume with 2,292 trades. The average volume for the last 3 months is 1,744,847 and the stock's 52-week low/high is $1.472/$20.0783996.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.